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ABSTRACT
Limbachia, Chirag. M.S.B.M.E., Department of Biomedical, Industrial, and Human Factor Engineering, Wright State University, 2015. Neural Correlates of Convergence Eye Movements in
Convergence Insufficiency Patients vs. Normal Binocular Vision Controls: An fMRI Study.

Convergence Insufficiency is a binocular vision disorder, characterized by reduced ability of performing convergence eye movements. Absence of convergence causes, eye strain,
blurred vision, doubled vision, headaches, and difficulty reading due frequent loss of place.
These symptoms commonly occur during near work. The purpose of this study was to
quantify neural correlates associated with convergence eye movements in convergence insufficient (CI) patients vs. normal binocular vision (NBV) controls, and to examine statistical differences between them. Functional magnetic resonance imaging (fMRI) scans were
collected using a 3T Siemens scanner. A disparity-driven convergence task was designed
using a standard block design approach, and was presented to all the subjects as a visual
stimulus. Subjects performed tasks of two difficulty levels; an easy and a hard convergence
task. FMRI data was analyzed using fMRI Expert Analysis Tool (FEAT) in FSL software
package, and statistical data obtained from the FEAT was further analyzed in JMP to assess significant factors and interactions. Results showed significantly higher activation in
the regions of interest (ROI), both in spatial extent and amplitude, of the patients compared
to the controls (z-score > 2.3, p< 0.05). JMP analysis showed, hard task elicited higher
activation than the easy task, in both controls and patients.
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Introduction

1.1

Purpose

To quantify neural correlates associated with convergence eye movements in convergence
insufficient patients and normal binocular vision controls, and to examine statistical differences between the two groups.

1.2

What is Convergence Insufficiency (CI)?

Convergence Insufficiency (CI) is binocular vision disorder characterized by inability of
the eyes to move inwards in order to look at near objects. For example, if an observer looks
at a distant target, such that the demand for convergence is negligible, the lines of sight
from both eyes almost run parallel. When the target is moved closer to the observer, the
demand for convergence increases as the lines of sight have to converge on the target for
the observer to view the target clearly. In presence of CI, the observer will have difficulty
converging his/her eyes. This disorder was first described in 1855 by von Graefe [1] and
later expounded in detail by Duane [2]. CI is characterized by: 1) remote near point of
convergence (NPC), 2) decreased positive fusional vergence (PFV) at near, 3) exophoria
grater at near than at distance [2, 3]. Therefore, to diagnose CI, it is important to measure
these three clinical parameters. The patients with CI may complain about symptoms such

1

as, diplopia (doubled vision), blurred vision, eye strain, headaches, difficulty reading due
frequent loss of place. These symptoms mainly occur while doing near work such as desk
work or computer work [4, 5, 6].

1.3

Prevalence of CI

Prevalence of CI varies over a wide range between 1.75-33% [7, 8, 9, 10, 11, 12, 13, 14]
with an average prevalence of roughly 5%. This broad range of variation is due to factors
such as, different CI definitions adopted by different authors, or the kind of sample studied [15]. Four population based studies have provided a range of 2.25% to 8.3%, for CI
prevalence [16, 17, 18, 19]. However, there was no consistency in the definition of CI across
these studies. Older studies have suggested CI being less prevalent among children because
symptoms are most often reported after the age of twenty or thirty [7, 8, 13, 14]. This claim
was based on the assumption that children spend less time doing near work compared to
young adults, therefore, they are less likely to complain about symptoms. However, newly
conducted studies by Convergence Insufficiency Treatment Trail (CITT) Study Group have
reported higher prevalence of CI even among children [19]. Some researchers like Rouse
[19] have noticed CI being hereditary, however, there hasn’t been any study that makes a
significant claim about it. Also, variations in prevalence of CI across different racial/ethnic
groups is also not been studied [15].

1.4

Symptoms

Complaints about tiredness and discomfort by the end of the day due to reading and computer work are some of the most common symptoms in CI patients [8, 13, 20, 21, 22].
Symptoms such as headache [11, 13], eye ache, sleepiness [11], and double vision [8, 11,
12, 13, 23, 24, 25], are also commonly occurring symptoms due to CI. Some of the symp2

toms that occur rarely include, dizziness [7, 8, 14], and nausea [3]. Some patients also
experience migraine which can be treated by therapy [26]. Perception of depth may also
be altered in CI patients which may cause them to poorly judge distance of objects in view
[3]. One study showed that many CI patients had more than one symptoms [27], whereas
another study showed that almost 18% of the CI patients were without any symptoms [24].
This asymptomatic condition of certain CI patients is supposedly due to high threshold for
pain, avoidance of near work [28], suppression [16], or monocular occlusion. Aforementioned symptoms that occur in CI patients during near work can affect their life negatively
by hindering their ability to read, write, comprehend, perform desk work, or any work done
at a close distance. It may also affect their leisure activities [4, 15].

1.5

Diagnosis of CI

There are three clinical parameters which are measured to diagnose CI; NPC, PFV, and
Exophoria at near.

1.5.1

Near Point of Convergence (NPC)

Near point of convergence (NPC) is a widely used clinical procedure to diagnose CI, because receded NPC is one of the most commonly found symptoms in patients with CI [2].
In fact, some authors use NPC as the only means to detect CI [16, 29]. NPC is measured
as follows; the examiner holds the tip of a pen, or any accommodative target, along the
midline, at the level of the patients eyes, and slowly brings it closer to the patient, until the
examiner notices one of the eyes of the patient at test drifts out, or until the patient reports
about not being able to fuse the image of the tip of the pen. The distance of this point is
measured and recorded as the breaking point of convergence. Then, the pen is moved away
from the patient, until the tip of the pen again appears single to the patient. This distance
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Figure 1.1: (A) In absence of base out prisms, eyes are properly converged on the visual
target, and a clear fused image is perceived by the patient. (B) Base out prism is placed
in front of the right eye. Therefore, to compensate for the diplopic image of the the visual
target caused by the light refraction through the prism, the patients has to converge his/her
right eye to view the target clearly.

is recorded as the recovery point of convergence. Measure of the closest distance from the
eyes, along the midline, until a point where the visual target appears single is NPC. Many
studies have used NPC test to detect CI, but there has been no uniformity in the method employed to conduct an NPC test, across these studies. These studies have suggested different
ways of performing NPC, and distance they propose based on their findings are spread over
a wide rage from 5cm to 11cm [2, 3, 10, 30]. Nevertheless, two studies that performed NPC
using different methodologies gave account of cut-off being ≤ 5 cm for adults [31] and ≤ 6
cm for children [32]. Since the difference between these two cut-offs was very small, they
are today widely used as standard cut-off values in an NPC test. Some studies have also
suggested to take into account patient’s other signs such as, retraction of head, appearance
of wrinkles on the forehead due to strain, and sweating while the NPC test is performed
[3, 30].

1.5.2

Positive Fusional Vergence

A reduced fusional convergence amplitude, or reduced PFV, at near is also a common
symptom in CI patients. Therefore, it becomes crucial to test potential patients for reduced
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PFV. A PFV test measures positive fusional reserves of a patient, i.e., maximum amplitude
of positive vergence, i.e., convergence a patient can perform. This test is carried out using
a base-out (BO) prism bar and a small accommodative visual target, such as a column of
20/30 letters. The prism bar consists of a series of prisms with increasing base thickness.
Base thickness is expressed in units prism diopters (PD), and with the symbol, ∆. The
step increment between the prisms in the prism bar is of 2 and 5 PD (∆). The patient is
instructed to look at the target while the examiner gradually slides the prism bar over one
of the eyes of the patient, giving just enough time to the patient to fuse the target. The
BO prisms cause light to refract outwards, towards the base of the prism, making the target
appear deflected towards the apex of the prism. Hence, to maintain fused image of the
target, the eye at test has to move inwards or converge [15]. The prisms are continuously
replaced in an incremental fashion to a point which the targets appears blurry or diplopic
and the patient is no longer able to fuse the target. The prism at this point is measured
and recorded as the break prism. After, the prism bar is slide backwards, i.e., the PD is
reduced, until a point at which fusion is regained. Prism at this point is recorded as the
recovery prism. Both breaking and recovery prisms are expressed in units PD or (∆).
Figure 1.1, demonstrates how eyes behave in presence of a base-out prism.

1.5.3

Exophoria at Near

Exophoria at near is characterized by outward deviation of the eyes when looking at a near
target. This happens when a patient is not able to sustain the state of convergence in order
to look at a near target. The degree of exophoria varies among the people who exhibit
exophoria at near.
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1.5.4

CISS

Convergence insufficiency symptom survey (CISS) consists of 15 questions with five response. The questions are based on symptoms that are commonly associated with CI.
The five response options provide five different frequency choices at which a particular
symptom occurs, from “never” through “always”. Purpose of this survey is to assess the
symptoms as well as the severity of the symptoms associated with CI. The response to each
question is weighted as per its frequency, and total score of the survey is calculated. The
minimum and maximum possible scores that can be scored in this survey are, 0 and 60,
respectively [15]. A study was conducted on children of age 9 to less than 18 years, to
check the validity of CISS [33]. The study involved both, children with CI and children
with normal binocular vision (NBV) taking the survey, and comparing their scores to see
if there was any significant difference between the two groups. The study concluded with
suggesting a CISS score > 16 as a good cut-off score for symptomatic CI. A similar study
carried out on adults of age 19-30 years, found CISS score > 21 to be a good cut-off score
for adults [34]. From both the studies mentioned above, it is evident that the cut-off score
for adults is higher than that of children. This is because, adults in general, choose an
answer of a higher frequency to each symptom compared to children, on the CISS. Also,
there were 6 questions on the survey to which adults and children responded significantly
differently. The answers chosen, or frequencies reported, by adults for symptoms like;
pulling sensation around the eyes, hurting eyes, eye soreness, tired eyes, blurry vision, and
eye discomfort, were much higher than those reported by children. Whereas, children reported higher frequency for symptoms like, loss of place while reading, drowsiness, and
slow reading. Given the meticulous nature of CISS in quantifying one’s CI condition, CISS
is considered to be a reliable tool to quantify symptoms in patients with CI, and it is also
widely used in clinical research. However, like all surveys, even CISS has it’s shortcomings. CISS is only effective in cases where a patient exhibits multiple symptoms. For
example, if a patient experiences only one symptom like blurred vision all the time. It may
6

well be due to CI, but when that patient takes the CISS survey, he/she may score as less as
5 points [15]. CISS is not used in diagnosing CI, however, Cooper et al (2012) suggested
that it should be used diagnostically to assess treatment induced changes in symptoms associated with CI [15].

1.6

Causes and Treatments

1.6.1

Causes

The most recent opinion of researchers about etiology of CI is that it is innervational. This
view is supported with strong evidence of treatment induced improvement in CI patients
[26].
CI is largely considered to be idiopathic, however, recent studies have shown evidence
to suggest that CI may also be caused by traumatic brain injury (TBI) [35, 36, 37, 38].

1.6.2

Treatments

There are several treatments available to treat symptomatic CI. It is important to note that
not all CI patients exhibit symptoms. In cases of asymptomatic CI no treatment is recommended [26]. CI treatments fall into two categories; active treatments, and passive treatments. Active treatments includes, home based pencil push-up therapy (HBPPT), home
based computer vision therapy (HBCVT), and office based vision therapy (OBVT). Passive treatments include; base-in prism glasses, and surgery.

Home-based Pencil Push Up Therapy (HBPPT)
This therapy is primarily focused on improving NPC [39]. It requires the patient to hold a
pencil at an arm’s length, maintaining its position on the sagittal plane. It then requires the
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patient to move the pencil closer to his/her nose while viewing the pencil clearly. When
the pencil gets blurry or diplopic he/she should move the pencil away until pencil appears
single and clear, again. If the patients is no longer able to fuse the image of the pencil,
this procedure is to be repeated. A background visual target is also used in this procedure
that serves as a suppression control [40, 41, 42]. This exercise is to be performed for few
minutes, several times a day. Studies have shown that treatment effect in CI patients treated
with HBPPT was not statistically different from those treated with placebo therapy [42].

Home-based Computer Vision Therapy (HBCVT)
This therapy is mainly focused on improving the positive vergence amplitude, also known
as PFV. Prior to 1980s, when computers had not become a common household device, a
traditional home based vision therapy was prescribed to treat CI. This therapy involved
use of a stereoscope, some devices that are readily available at home, and some prisms.
However, in last decade, due proliferation of computers in almost every house, this therapy
has been replaced by HBCVT [43, 44]. Technological advancement and use of HBCVT
provided advantage over the traditional home based vision therapy, such as, therapy was
carried out in a more structured manner with the help of software, tracking the performance of patients during the therapy and also measuring their adherence became easy, and
the computer also provided feedback for patients performance. It created charts and graphs
of patients progress for the current session as well as for progress over several previous
sessions. Effectiveness of this treatment is still a matter of debate. Numerous smaller studies have reported computer based therapy being effective in reducing symptoms associated
with CI and improving positive fusional reserves (PFV) [45, 44, 46, 47]. However, these
studies were carried out not at home but in an office environment. The only study conducted which involved computer based therapy done at home was a study by CITT group
[6]. This study reported no significant effect of HBCVT in treating CI.
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Office-based Vision Therapy (OBVT)
An office based vision therapy involves CI patients regularly visiting office, once or twice
in a week, where they are given a vision therapy by a therapist. Along with regular office
visits, patients are also required to perform some supplementary therapy procedures at
home, everyday or 5 days per week. Generally, an OBVT lasts for until 10-20 office visits
[15, 48]. CITT studies [49, 42, 6] found that OBVT, coupled with supplementary home
therapy procedures, was significantly more effective than HBPPT, HBCVT, or placebo
therapy, in treating CI.

1.7

Clinical Significance of CI

CI is clinically significant because it impairs the binocular vision system by reducing a
person’s ability to perform convergence eye movement. This deviation from normal functioning of binocular vision results in several discomforting symptoms mentioned in earlier
sections.

1.7.1

What is Binocular Vision?

Development of binocular vision system in humans due to frontal placement of eyes through
evolution has accorded humans the ability to achieve single vision and perceive depth of
the scene in view. Single vision is achieved through coordinated movements of both eyes
which assist in fusing slightly different images seen by each eye. Depth perception in
binocular vision system is achieved by the mechanism called stereopsis [50]. Basically, a
normal alignment of both eyes constitutes normal binocular vision. Any condition which
alters the normal alignment of the eyes can affect a person ability to achieve single vision
or perceive depth. The eye movements which are crucial in maintaining binocular attribute
of the human vision system, and stabilizing retinal images, are of six types; fixation, pur-

9

suit, saccade, optokinetic, vestibular, and vergence. There are six extraocular muscles that
make these movements possible, four of which are medial, lateral, inferior and superior
recti muscles, and the other two are inferior and superior oblique muscles. The inferior
oblique, medial, inferior, and superior recti muscles receive innervation form ocularmotor nerve. Lateral recti and superior oblique muscles are innervated by the abducens and
trochlear nerves, respectively. This thesis will only focus on vergence, and more specifically convergence eye movement [51].

Vergence Eye Movement
Simultaneous horizontal movement of both eyes in opposite direction is called as vergence.
Vergence is also referred to as disjunctive eye movement [52, 53]. It serves in maintaining
stimulus of an object on corresponding retinal areas of both eyes for proper fusion, by
changing the gaze distance. Simultaneous outward movement of the eyes to look at far
away objects is called divergence, and simultaneous inward movement of the eyes to look
at near objects is called convergence.

1.8
1.8.1

Motivation for Study
Previous Findings

Several studies in past conducted on primates and humans have investigated the neural
networks that encode convergence eye movements. Involvement of cortical regions in the
posterior parietal cortex (PPC) in encoding convergence response was reported by some
studies that were conducted on primates [54, 55, 56, 57]. Involvement of certain regions
within the frontal eye field (FEF) in mediating convergence response was also reveled by a
single cell study performed on primates [58]. Involvement of the cerebellum in mediating
convergence eye movements was reported by several studies [59, 60, 61, 62, 63, 64, 65].
10

Takagi et al (2003) and Sander et al (2009) showed that lesions in the cerebellum vermis
(CV) were the reason for impaired convergence ability in primates and humans, respectively [63, 66]. Distinct cells in the midbrain, in the mesencephalic reticular formation,
dorsolateral to the oculormotor nucleus were found to be active during convergence eye
movements in single cell studies conducted by Mays et al (1984, 1986) and Zhang et al
(1991, 1992) [67, 68, 69, 70]. Many studies have also investigated role of dorsolateral
prefrontal cortex (DLPFC) in regulating eye movements. A study by Pierrot-Deseilligny
et al (2005) had reported DLPFC playing the role of a predictive controller in predicting
anticipatory saccadic eye movements [71]. Building on this, Alvarez et al (2010b) showed
there that was no difference in the activation induced in DLPFC due to predictive saccade
or predictive vergence [72]. Alvarez et al (2010a) also showed in a study performed on
CI patients that the activation in the following regions; FEF, DLPFC, part of parietal lobe,
cerebellum and brain stem, increased both in spatial extent and amplitude after vision therapy [73]. Another similar study by Alvarez at el (2014) that compared functional activity in
CI patients and binocular vision controls, reported that activation in FEF, posterior parietal
cortex (PPC), and CV in controls was significantly higher than in the same regions of the
CI patients during the baseline run, and the activation in the same regions of the patients
increased after 18h of vision therapy [74].
The purpose of this study is to investigate differences between the neural activity
elicited due to disparity driven step convergence eye movements in CI patients and normal controls, not limited to the brain regions of interest (ROIs) mentioned in the studies
above, and to find out if the outcomes of this study correlate with previous findings.

1.8.2

Hypothesis

This study hypothesizes that activation in the CI patients will be significantly higher in the
ROIs, both in terms of spatial extent and amplitude, than the normal controls.
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Background
Around mid 20th century, it was a common understanding that brain exhibited functions
that were localized. Experience of dealing with patients with traumatic brain injuries (TBI),
and neurosurgeries performed involving cortical stimulations, further added evidence that
human brain functions are localized and specific. However, these inferences were based
on observations made on damaged brains. It was during the late 20th century, when new
imaging modalities were developed that assessed brain functions even in healthy brains
using non-invasive means. These new imaging modalities opened up countless avenues in
the field of neuroscience research. One such modality which is extensively being used in
neuroscience research, and now also making inroads into clinical realms, is functional magnetic resonance imaging (fMRI). The ability of this tool to report brain functions in form
of volumetric brain maps has made it a popular imaging modality among neuroscientists,
in the last two decades. Before specifically talking about functional MRI, it will be helpful
to understand what magnetic resonance imaging (MRI) itself is? MRI uses the principle of
nuclear magnetic resonance (NMR) to generate contrast images. MRI is performed using
an MRI scanner. Figure 2.1, is a imitation of one such superconducting MRI scanner. An
MRI scanner constitutes of three essential components that play central role in generating
contrast images; magnet, gradient coils, and radio frequency (RF) coils.
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Figure 2.1: Cutaway view of an MRI scanner with its essential components; magnet, gradient coils, and RF coils.

2.1

What is Magnetic Resonance Imaging (MRI)?

MRI is a non-invasive, non-ionizing radiation imaging technique which is used for imaging
biological structures and getting anatomical information of the body. The magnet referred
to, in context of MRI, is a massive coil of wire that is subjected to a constant flow of electric
current. This constant current flow generates a homogeneous magnetic field (B0 ) inside the
bore of the MRI scanner. Magnetic strength of such superconducting MRI scanners varies
from 1.5T to 7T [75, 76, 77]. 1.5T to 3T is the standard field strength used in clinical
settings, currently. However, for research purpose, a scanner of magnetic strength as high
as 7T can be used. Research that involve animals may even use a higher field strength
scanner of up to 8T [78, 79]. To understand the magnitude of the field strength played
with, during an MR scan, it is important to know that the field strength of an MRI scanner,
particularly of 1.5T and 3T system, is 30,000 to 60,000 times the magnetic field strength of
the Earth [80]. Thus, it is obligatory that a proper, coherent, safety procedure is followed
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Figure 2.2: (left) Three gradient coils; Gx , Gy , and Gz . Meant to acquire images in all
three planes; axial, sagittal, and coronal. (right) Siemens 8 channel RF head coil to image
brain.
to keep all ferrous objects out of the MRI magnetic field vicinity, in order to prevent any
accidents or damages. Gradient coils in an MRI scanner act exactly as their name suggest,
“gradients”. They can be thought of as temporary magnets which can be turned on and
off to create field gradients in the already existing B0 field, inside the bore. Figure 2.2
(left), provides a pictorial representation of how these coils are oriented within the MRI
scanner. The subdivision of the gradient coils into, Gx , Gy , and Gz coils is meant for
acquiring images in all three planes, namely; axial, coronal, and sagittal plane. The RF
coils are meant to transmit and receive radio frequency pulse into and out of the body
part being imaged. Figure 2.2 (right), represents one such RF coil, specifically designed to
perform brain imaging. It is a Siemens 8-channel RF head coil. A more detailed description
as to how these three components function together to generate contrast images will be
mentioned in Section 2.1.1.

2.1.1

MRI Physics

Human body constitutes of several elements, hydrogen (H) being present in most abundance as 71% of the body is water (H2 O). Since hydrogen has only one proton, it can be
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Figure 2.3: (A) Represents single hydrogen nucleus and its behavior in presence of B0
field. Net magnetization vector M is formed due to collective alignment of hydrogen nuclei
along the B0 field. (B). Random orientation of hydrogen nuclei in the body in absence of
B0 field. Adapted from Kashou 2014 [80].

simply called as a proton or a hydrogen nucleus. Therefore, terms like hydrogen protons,
hydrogen nuclei, or just protons will be used interchangeably in this thesis. These hydrogen nuclei spin about their own axes, and have a certain magnetic dipole moment (MDM).
They behave as magnetic dipoles. In presence of no external magnetic field, the hydrogen
nuclei/protons are randomly aligned, such that the net MDM of all the protons in the body
is zero. Figure 2.3 (B), represents a scenario when net MDM is zero.
When a subject lies inside the MRI scanner, the hydrogen protons get mobilized by the
B0 field, and they align themselves in direction either parallel or anti-parallel to the B0 field.
Such mass alignment of protons creates a net magnetization vector (M ) in the direction of
the B0 field. This state is called as an equilibrium state or a lazy state of protons [80].
Along with aligning themselves, the protons also start precessing about an axis parallel
to the B0 field. Figure 2.3 (A), represents one such hydrogen proton that precesses about
B0 axis, along with its orientation in the space. The frequency at which hydrogen nuclei
precess is called the Larmor frequency. Following is the equation for Larmor frequency,
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ω0 = γB0

(2.1)

Where B0 is the externally applied homogeneous magnetic field, γ is proportionality
constant, also known as gyromagnetic ratio, and ω0 is the precession angular frequency.
The gyromagnetic ratio (γ) is the property of a particular nucleus. For hydrogen nuclei,
the gyromagnetic ratio (γ) is 42.6 MHzT−1 . From the equation above, it is evident that
ω0 is directly proportional to the B0 field. It is crucial to know the precession frequency
of hydrogen nuclei in order to conduct MR imaging. Once the precession frequency is
determined, the third essential component of MRI, the RF coils, comes into play. RF coils
transmit RF pulse of a frequency that match with the precession frequency (ω0 ) of hydrogen
protons. Due to the matching frequencies of the RF pulse and precessing protons, resonance
takes place. The resonance results in absorption of energy by the hydrogen protons from
the RF pulse, and hydrogen protons get pushed into a high energy state. This causes the
net magnetization vector M to deflect from its equilibrium position. The deflection of the
net magnetization vector M can be represented into Mz and Mxy components.

Mz (t) = M0 (1 − exp−t/T 1 )

(2.2)

Mxy (t) = M0 exp−t/T 2

(2.3)

Here, M0 is the original net magnetization vector at equilibrium state before the
RF/excitation pulse is applied. Mxy is the transverse magnetization vector that gets orientation in the x-y plane after the excitation pulse is applied. Mz is the longitudinal vector
that gets realigned with the B0 field after the excitation pulse disappears. T1 and T2 are
time constants. Figure 2.4, illustrates the curves for Equations 2.2 and 2.3. These curves
are also known as T1 and T2 relaxation curves. T1 and T2 relaxation curves form the basis
for generating contrast images.
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Figure 2.4: (A) Alignment of protons with the B0 field, and deflection of protons after
excitatory pulse is applied. (B) T1 and T2 relaxation of the protons in three dimensional
space. (C) T1 and T2 relaxation curve equations. Adapted from Kashou 2014 [80].

To understand the physics involved in MRI in more depth, consider a subject that
has gone through a coherent MRI safety procedure to keep all the ferrous material out of
the vicinity of MR scanning room. He/She is then put in the MRI scanner. Now, under the
presence of B0 field, hydrogen nuclei in the body get aligned and create a net magnetization
vector along the B0 field. At this stage, shimming is carried out. Shimming involves
calibration and fine tuning of the MRI scanner [80]. Next, an RF pulse of a frequency
which is determined using the Larmor Equation 2.1, is transmitted to target those protons
that precess at the same frequency as the RF pulse. Due to the matching frequency of RF
pulse and protons, resonance occurs. This resonance results in protons absorbing energy,
and the net magnetization vector (M ) gets deflected at an angle that is predetermined by
the RF pulse, typically a 90° RF pulse is used in an MRI procedure. Since the protons
cannot sustain the high energy state after the RF pulse is tuned off, they tend to return
back to their equilibrium state, i.e., they realign themselves with the B0 field. As a result,
the net magnetization vector (M ) also realigns with B0 field. During the realignment,
protons release energy in form of radio waves. This realigning process or energy release
is called as relaxation. Relaxation of the net magnetization vector are of two types, as
mentioned earlier; T1 and T2 relaxations. T1 relaxation is the realignment of protons with
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B0 field, therefore, it is also called as longitudinal relaxation, and it’s relaxation curve
is expressed as the Mz component (Equation 2.2). Spinning protons release energy to
their surrounding lattice in form of radio waves (Figures 2.4 (2a) and 2.4 (3a)), during T1
relaxation. Therefore, T1 relaxation process is also called as spin-lattice interaction.
T2 relaxation is much more complicated than T1 relaxation. Firstly, know that, although T1 and T2 relaxations take place simultaneously, they are independent of each
other, because T1 happens along the z-axis and T2 happens on the x-y plane. T2 relaxation
takes place due to dephasing of the protons. Before any excitatory pulse is applied, the protons under the influence of the B0 field precess at the same frequency but out of phase. For
example, clocks all over the world tick at the same rate, but they don’t show the same time.
Which means, the arms of the clock are spinning at the same frequency but out of phase,
as they don’t point in the same direction. Similar is the condition of protons under the B0
field. However, when a 90° excitatory pulse is applied, along with orienting themselves on
the x-y plane, protons also get in phase and point in the same direction. Now, every clock
in the world shows the same time, going by the clock analogy. After the RF pulse is turned
off, the protons which are pointing in the same directions interact with each other. Here,
as mentioned earlier that protons behave as dipoles, the individual magnetic field of each
spinning proton interacts with each other, and due to the repulsion/attraction effect, some
protons start precessing faster and some start precessing slower, causing protons to point in
different directions, resulting in dephasing. During the dephasing, protons release energy
in form of radio waves. This process of depahsing is called as T2 relaxation or spin-spin
interaction. Since T2 relaxation takes place on the x-y plane it is called as transverse relaxation, and its relaxation curve is expressed as Mxy component (Equation 2.3). Figures 2.4
(2b) and 2.4 (3b), is a simplified graphical representation of the dephasing or T2 relaxation
process of the protons.
During both T1 and T2 relaxations, radio wave signals are emitted by relaxing protons, also known as finite induction decay (FID) signal, which can be measured at any time
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during the relaxation phase, by the RF coils. The choice of time as to when the measurement is to be made, holds the key to achieving desired contrast images. During an MRI
procedure, the RF pulse is repeatedly applied over a certain interval of time known as repetition time (TR), and the choice of time after each RF pulse to measure the echo signal
is known as the echo time (TE). Appropriate choice of TR and TE is dictated by the type
of contrast one desires to achieve. Three most common contrast used in MR imaging are,
T1, T2, and proton density (PD) weighted contrast. T1 weighted contrast simply implies
that contrast images are generated by exploiting the different T1 relaxation times of different tissues. For example, in brain imaging, the T1 relaxation time of cerebral spinal fluid
(CSF) is longer than that of the white matter (WM), i.e., protons in CSF take longer to align
themselves with the B0 (longitudinal relaxation) than the protons in WM. This results in a
brighter signal from WM and a darker signal from CSF. Whereas, for a T2 weighted image,
the signal from CSF is brighter than the WM, because dephasing of protons (transverse relaxation) is slower in CSF compared to WM. PD weighted images fall between T1 and T2
weighted images.
So far, the interaction of protons with the externally applied B0 field, and the role
of RF coils is expounded. However, the process of acquiring MR images is incomplete
without the use of gradient coils. The gradient coils play an important role in selecting the
regions of the body to be imaged. It was mentioned earlier that gradient coils function to
create field gradients in the existing B0 field. During the process of an MRI scan, these
three gradient coils (Gx , Gy , Gz ) perform three different functions; slice encoding (slice
selection), phase encoding, and frequency encoding. It is arbitrary as to which gradient
performs which function, but for ease of understanding, this thesis will follow the convention of Gz performing slice encoding, Gy performing phase encoding, and Gx performing
frequency encoding. During the slice encoding process, the Gz is switched on, such that
it’s magnetic field BG is superimposed on the B0 field. This creates a field gradient with
slightly increased field strength (B0 + BG ) at one end of the bore and slightly decreased
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Figure 2.5: Slice is selected by varying the magnetic strength along a particular axis, in this
case z-axis, using the slice select gradient, and then sending RF pulse of the frequency that
matches the precessing frequency of protons of the desired location. Slice thickness selection is carried out simultaneously by choosing an RF pulse of a user specified bandwidth.
Adapted from Kashou 2014 [80].

field strength (B0 − BG ) at the other end of the bore, as described in Figure 2.5. Recalling
Larmor Equation 2.1, and knowing that the protons’ precession frequency is directly proportional to the field strength, the protons at the inferior region of the body like abdomen
will precess at a lower frequency than the protons in the superior region like head. Making
protons to precess at different frequencies by manipulating the field strength with the help
of gradient coil (Gz ), helps to selectively target protons at the desired location (slice) in
the body. This is done by accessing larmor frequency of protons in a particular slice by
knowing the field strength at that slice, and then sending RF pulse of the same frequency.
Therefore, the echo signal received from the resonating protons would mark the location
of that slice. The slice thickness is also determined during slice selection process by user
specified RF pulse bandwidth.
Once the slice is selected using the Gz coil, phase encoding is carried out by the Gy
coil in order to encode spatial information of the selected slice. This is done by briefly
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Table 2.1: Gradient coils, their functions and directionality
Gradient coils
Function
Gz
Slice encoding
Gy
Phase encoding
Gx
Frequency encoding

Information encoding direction
Superior-Inferior
Anterior-Posterior
Right-Left

switching on the Gy coil to create a field gradient in an anterior-posterior direction. When
this field gradient is applied, the precession frequency of the protons in the selected slice
varies along the y-axis, i.e, protons in the anterior region of the slice precess faster than
the protons in the posterior region. This causes protons to go out of phase. When the Gy
is switched off, the protons again start precessing at the same frequency but remain out of
phase. Now, since the protons are precessing at different phases, the signal received will
be a bunch of RF waves that have different phases. This information helps in encoding an
array of points in the anterior-posterior direction (rows), on the selected slice.
Now, in order to encode spatial information in the left-right direction, frequency encoding is carried out by using the Gx coil. In frequency encoding process, the Gx coil is
turned on, which applies a field gradient in the left-right direction and cause protons to
precess at different frequencies from left to right, let say, the protons on the left hand side
precess slower than the ones on the right hand side. This further adds to the phase shift
of the already out of phase protons from phase encoding process. Therefore, RF waves
of different frequencies in the received signal help in encoding an array of points in the
left-right direction (columns), on the selected slice.
Reiterating that the use of three gradient coils is arbitrary and entirely dependent on the
user’s choice, for the simplicity of understanding, this thesis uses the following convention;
Gz for slice encoding, Gy for phase encoding, and Gx for frequency encoding. Therefore,
the image acquisition is in axial fashion. Table 5.1, is a summary of functions preformed
by the three gradient coils.
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2.1.2

Image Acquisition

Aforementioned physics involved in MR imaging gives a general idea of how the magnetic
properties of protons are exploited by the B0 field, RF coils and gradient coils, in order
to extract information about protons’ behavior which is later used to generate images. The
images acquired during an MRI scan are three-dimensional (volumetric) spatial maps. During the phase encoding (PE) process, it was mentioned that information is encoded in the
anterior-posterior direction. Which means, the selected slice is divided into number of
rows, where each row encodes a signal of a different phase. During the frequency encoding (FE) process, it was mentioned that information is encoded in the right-left direction.
Which means, the selected slice is divided into number of columns, where each column
encodes a signal of a different frequency. The third process of slice encoding selects a slice
at a certain location along the superior-inferior direction, and of a certain thickness which
is determined by the user defined pulse bandwidth. These three processes determine the
resolution of the images by designating number of PE points (columns), FE points (rows),
slice thickness (ST), number of slices, and field of view (FOV). Each encoded point in
the FOV has a certain size in all three directions which is dependent on total number of
points in each direction (x,y,and z). The product of these three sizes gives the size of a
voxel (Figure 2.7). Voxels are analogous to pixels in two dimensional space. The encoded
information is stored in a space called k-space which the MRI scanner converts into image
space through inverse fast fourier transform (IFFT) (Figure 2.6). It is out of the scope of
this thesis to talk about IFFT in detail. After the information is converted into image space,
it is represented in form of intensity value in each voxel. Typical size of a voxel is 1.0 x 1.0
x 1.0 mm for anatomical scans and 3.0 x 3.0 x 3.0 mm for functional scans. To get a grasp
on voxels, consider an anatomical brain scan of a voxel resolution of 1.0 x 1.0 x 1.0 mm.
The anatomical image of the brain contains ≈700,000 voxels. Figure 2.7, illustrates how
brain is divided into number of voxels.
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Figure 2.6: Representation of how information is encoded in k-space using a particular
image sequence (in this case, and EPI/fMRI sequence), with the help of gradients, and
converted into image space. Adapted from Kashou 2014 [80].

2.1.3

Image Quality

There are many factors that affect MR image quality; resolution (voxel size), TR, TE,
number of excitations (NEX), also knows as number of signal averages (NA). These factors
are interdependent, which means, exploiting one of them to get a better image quality will
influence the ability of other factors to produce a good quality image. For example, if TR
is long, it will allow more number of slices to be acquired, but at the same time it will
reduce the T1 contrast. Also, having longer TR prolongs the scanning time, which is not
very economical. On the other hand if the TR is shortened, the T1 contrast will increase,
but there will be fewer number of slice, and also the SNR will be low. If the TE is long,
the T2 weighted contrast will be high, however, it will have a low SNR. Whereas, if TE is
shortened, it will increase the SNR but will reduce the T2 contrast.
The phase encoding (PE) process influences the image quality, as well. If there are
higher number of PE points (rows), it will increase the resolution but will prolong the
scanning time. This is because each row of the K-space has to be encode with a new
RF-pulse, i.e., only one row is encoded during each TR [80].

2.2

What is fMRI?
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Figure 2.7: Illustration of resolution of an MRI image. The image is constructed of several
voxels. The voxel resolution in this image is 3.0x3.0x5.0 mm. Adapted from Kashou 2014
[80].

In last couple of decades, many techniques have been developed in an attempt to quantify functionality of the human brain. The two most common techniques used in mapping
brain functions have been those that map brain functions by quantifying the electric signals
elicited due to neuronal firing, and those which measure the metabolic changes elicited by
increased neural activity. Electroencephalography (EEG), and magnetoencephalography
(MEG) are two non-invasive techniques that fall in the category that measures electric signals. Although, these techniques provide an impressive temporal resolution of the neural
activity, they have a poor spatial resolution of 1 centimeter and more. Functional magnetic resonance imaging (fMRI), which falls in the category that measures the metabolic
changes, is also a non-invasive and non-ionizing radiation imaging technique, but has a
better spatial resolution of up to only few millimeters and a reasonably good temporal resolution of few seconds which is dictated by the heamodynamic response. Hemodynamic
response is expounded later in this chapter. FMRI can be made sensitive to the local blood
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flow, and oxygen content in the blood. Blood oxygenation level dependent (BOLD) contrast imaging is one such commonly used method in fMRI. In BOLD contrast imaging,
MRI is made sensitive to the local blood oxygen levels in order to map brain functions
[81].
The basic physics involved in acquiring fMRI images is similar to that of MRI which
is mentioned in the Section 2.1.1. However, the image sequence employed for acquiring
fMRI images differs from the sequence employed in acquiring MRI images (anatomical
images). An image sequence is defined by the image acquisition parameters; TR, TE, flip
angle (FA), spatial resolution. Figure 2.8, illustrates the comparison between an anatomical
image and a functional image. The difference that is most evident is the spatial resolution.
Anatomical image is a volumetric brain map, extending in three dimension of space, typically with a spatial resolution of ≈1mm3 isotropic. Whereas, functional image is also
a volumetric map, with a poorer spatial resolution of ≈3mm3 isotropic, and with multiple volumes acquired over time. This makes functional images a 4D dataset, with time
as the 4th dimension. Before knowing as to why multiple volumes are acquired for an
fMRI dataset, it is important to know that fMRI compensates spatial resolution for a better
temporal resolution (to acquires as many volumes in a limited time) [82]. An anatomical
image sequence takes up to 5 mins to image an entire brain and produce one brain volume,
whereas, more than 100 brain volumes can be produced in 5 mins using the fMRI image
sequence. The reason for producing multiple brain volumes during an fMRI scan is to look
at the changing blood flow in the brain over time. Observing the changes in the blood flow
provides information about the metabolic activity of neurons in the brain. The other difference between an anatomical scan and functional scan is; during a functional scan, the
subject in the scanner is performing some task which is meant to elicit neural activity. On
the other hand, during an anatomical scan the subject does nothing, and simply rests in the
MRI scanner without moving.
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Figure 2.8: Illustration of difference between an anatomical image and a functional image.
The anatomical image to the left is a single brain volume with a high spatial resolution, and
the fMRI image is am entire dataset of several brain volumes with a low spatial resolution.
Adapted from Kashou 2014 [80].

2.2.1

Blood Oxygen Level Dependent (BOLD) Effect

BOLD effect is the most widely employed fMRI imaging method to access brain functions. In this method, the differing magnetic properties of hemoglobin, depending on its
oxygen saturation levels, are exploited [83]. It is a well establish fact that oxygen-carrying
hemoglobin (OxyHb) is transported to different parts of the body including the brain, via
blood, and blood brings back deoxyhemoglobin (deoxyHb) to the lungs for re-oxygenation.
At its saturated oxygenation levels, hemoglobin (oxyHb) has diamagnetic properties, thus
creating no interference or distortion in externally applied homogeneous B0 field. However, the hemoglobin that is devoid of oxygen atoms (deoxyHb) has paramagnetic properties which causes interference in the B0 field, and creates field inhomogeneity in the local
region [83, 84, 85]. This interference with the B0 field causes shortening of T2* relaxation
time [81, 86]. T2* relaxation is similar to the T2 relaxation which was expounded in earlier sections, however, besides being dependent on the spin-spin interaction like T2, T2* is
also influenced by the B0 field. The shortening of T2* relaxation implies fast decay of the
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Figure 2.9: The process of neurovacular coupling. Adapted from Metthews 2004 [81].

T2* (BOLD signal). Therefore, brain regions where concentration of deoxyHb is high are
represented as low intensity voxels in functional brain images, whereas regions dominated
by the oxyHb will show up as bright voxels. Blood circulation in the brain which involves
supplementation of oxygenated blood (oxyHb) and depletion of deoxygenated blood (deoxyHb), carries on constantly even when a subject is not involved in any task. The question
then is, how can the stimulated/active regions of the brains be distinguished from the regions that are at basal/resting state, using the “BOLD” effect method?
Well, to be able to ’milk’ the BOLD effect method in order to decipher brain functionality, one needs to understand neurovascular coupling mechanism of neurons and the
vasculature, and be acquainted to experimental BOLD response models developed over the
last decade [87].

Neurovascular Coupling
As per the above description of how concentration of oxyHb and deoxyHb affect the T2*
signal (BOLD signal) intensity, it may be quite intuitive for one to believe that brain region that is active will translate into low intensity voxels in an fMRI image, by the simple
understanding that high oxygen consumption leads to depleted local oxyHb concentration
vis-a-vis deoxyHb concentration, and therefore resulting in a lower BOLD signal [88].
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Figure 2.10: Description of the process of BOLD signal generation. Stimulus or task
triggers neural activity which results in increased cerebral blood flow in the local area,
eventually resulting generation of BOLD signal. Adapted from Kashou 2014 [80].

However, opposite is the case. The regions that are active, translate as bright voxels in an
fMRI image. This is due to neurovascular coupling process. When the metabolic demand
of active neurons rises, oxygen is transported to the neurons through various components
of blood (red blood cells, and plasma), and interstitial space in a passive manner [89]. For
such passive transport to occur, a pressure gradient is necessary which is provided by increased blood flow in the active region. This results in an increased local concentration
of oxyHb giving rise to higher BOLD signal intensity which goes on to show up as bright
voxels in an fMRI image. Figure 2.9, illustrates the neurovascular coupling process. During the basal/resting state, the local cerebral blood flow is at its baseline, ratio of

oxyHb
deoxyHb

is at its basal level, and therefore BOLD signal obtained is of normal intensity or of relatively lower intensity. During the stimulated/active state, to meet the neurons’ metabolic
demands, there is increased blood flow leading to higher cerebral blood volume (CBV),
which increases the

oxyHb
deoxyHb

ratio, resulting in slower BOLD signal decay, and therefore

resulting in a high signal intensity [90, 91, 92].
As much as simple and easy to understand one may find, the mechanism of neurovasular coupling is much more complicated. It is not fully corroborated with empirical evidence
that consumption of oxygen is higher in the active brain areas than the inactive ones. Few
studies have found that the blood flow, or the BOLD signal elicited due to blood flow, and
neural activity are not linearly related [93], and the BOLD signal is driven by local field potential created by a cluster of cells (neurons) rather than the individual neural firing [94, 95].
It is also found that blood flow associated with activation is more dominant in the dendrites
than in cell body of the neurons [94]. This amounts to uncertainty in finding precise loca28

Figure 2.11: BOLD response to an impulse stimulus is an HRF.

tion of the active neurons, as fMRI is only sensitive to the blood flow. Therefore, fMRI is
only an indirect measurement of brain functions. Nevertheless, several fMRI studies have
provided results that are in compliance with functional brain networks established through
other non-fMRI studies like human lesion studies and studies on primates [86]. They have
supported the assumption that increased neural activation results in increased BOLD signal.
Despite the complications and ambiguity associated with neurovascular coupling process,
it’s basic principles of hemodynamic response to brain activities, are being successfully
used by fMRI and other modalities [94]. Figure 2.10, is a simplified representation of the
process from stimulus on-set to acquiring the BOLD signal.

Hemodynamic Response Function (HRF)
BOLD response to a brief neural activation triggered by an hypothetical impulse stimulus
is known as hemodynamic response function (HRF). Figure 2.12, represents the shape of
an HRF curve. At the onset of a stimulus, there is an increased consumption of oxygen
in the active brain region leading to decreased

oxyHb
deoxyHb

ratio. This results in an initial dip

in the % MR signal (BOLD signal) [96]. Then, to compensate for the oxygen depletion,
blood flow increases leading to an increased

oxyHb
deoxyHb

ratio in the vicinity, causing the %

MR signal to rise. If the stimulus persists, followed by sustained neural activity, the % MR
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Figure 2.12: Hemodynamic response to an impulse stimulus. Adapted from Amaro 2006
[87].

signal reaches a plateau [97]. If the stimulus ceases, the %MR signal peaks and returns to
the baseline followed by and an undershoot [89]. The peak occurs at 5-6 seconds after the
stimulis onset, and the HRF decays to the baseline in 15-20 seconds [98]. The undershoot
is attributed to slower venous response in normalizing blood volume, to a relatively faster
blood flow, leading to a temporary increase in local deoxyHb concentration [99]. The
times of peak and decay of the HRF varies across people of different ages [98, 100]. The
characteristic curve of HRF is a fundamental BOLD response model which can be used
to design more complex experimental BOLD response models, or to put in more general
terms, fMRI paradigms. The following example can help better understand HRF. Consider
a scenario (Figure 2.11) where a brief flash of light is presented to an observer. The stimulus
is instantaneous in time, but the BOLD response to the stimulus is an HRF.
The basic idea behind the BOLD method is to create two types of contrasts in order
to obtain functional brain maps. The earlier sections have already elaborated as to how
spatial contrast can be achieved between active and passive brain regions, by looking at the
oxygen saturation levels of blood. However, spatial contrast is not enough to map brain
functions. Spatial contrast in combination with temporal contrast is needed to decipher
brain functionality. Temporal contrast is associated with fMRI paradigms which will be
talked in detail in the next section.
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2.3

fMRI Paradigms

Temporal contrast helps in extracting information of brain’s functionality over time by
presenting different stimulus condition that are time dependent. This temporal contrast is
achieved by designing a strategically constructed, and temporally organized stimulus condition model, also known as an fMRI paradigm. There are three common fMRI paradigms;
block, event-related, and mixed design.

2.3.1

Block Design

Block design is based on comparing the difference between the baseline condition to the
stimulated condition of the brain. A typical block design involves presenting at least two
stimuli conditions as alternating blocks. For example, condition A presented for 20 seconds, followed by condition B for 20 seconds. Such design is called as an ’AB block’
design, where condition A can be any task, and condition B can be another task, or just a
rest condition. Most commonly employed two conditioned block design is one in which
rest condition is alternated with a task condition, e.g., if A is rest and B is task, the design
looks like ABABABA, over several blocks. Starting with a rest condition and ending with
a rest condition is a good approach in a block design as it allows to measure brain activity from the baseline level. There can also be a third condition C which can be presented
along with other two conditions in several combinations, resulting in a three conditioned
block design. Having a subject engaged under different conditions, in a blocked fashion,
makes it possible to extract his/her brain response (BOLD response) by modeling a predicted BOLD response based on the block design, and comparing it to the actual BOLD
response of the brain, during functional data analysis. Figure 2.13, is an example of one
such ’AB block’ design where an on condition of flashing checkerboard is presented to
an observer for 20 seconds, alternated with the off condition of the checkerboard for 20
seconds. Each flash of checkerboard, during the on condition, is considered as a trial
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Figure 2.13: Flashing checkerboard results in neural activity, overall neural activity curve
is predicted and convolved with the HRF to get predicted BOLD response.

that elicits some BOLD response. Presenting several such trails during the on condition,
taking its average, and modeling a block design, helps in achieving high signal-to-noise
ratio (SNR) for the BOLD signal. The predicted BOLD response to the task is calculated
mathematically by convolving block design curve with the HRF. Although, block design
makes it easy to model BOLD response, it also introduces confounding factors like habituation and prediction. Presentation of stimulus as repetitive blocks of consistent periods
may trigger activation due to prediction along with activation due to engagement in task.
Despite the criticism this design has received for its strategy of making subtraction comparison and assuming several aspects of neuro-physiology, it has reigned the functional brain
research industry because of its robustness in producing results of high statistical power
[101, 102, 103, 104, 105, 105], and BOLD signal that is highly distinguishable from the
baseline [89, 106].

2.3.2

Event Related Design

Unlike block designs where several trails, during the active phase, are averaged and modeled as one block, an event-related design models each trail individually, with each trail
lasting for a duration of as small as 34-2000 milliseconds [107, 108, 109, 110, 111]. Which
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means, event-related design models transient BOLD response. Due to short duration of
the trials, this design yields an improved temporal resolution, and allows randomization of
events (different trials) or inter-trail-intervals (ITI) to eliminate training effect and habituation. Dale (1999) demonstrated that trials spaced as little as 2 seconds can still be called
apart as their BOLD response are added approximately linearly [112]. Burock et al (1998)
showed that by randomizing the order of stimuli presentation, the ITI can be reduced to
as brief as 500 milliseconds [113]. However, improved temporal resolution comes at the
expense of low SNR of the BOLD signal. There is empirical data that suggests SNR is
reduced by roughly 33% going from a block design to an event-related design [110]. Bandettini et al (2000) showed that for a stimulus with a fixed duration of 2 seconds and less,
the appropriate ITI is 12 seconds [110]. SNR can be slightly improved by presenting more
trials within the course of the experiment by using randomized short duration ITI [110].

2.3.3

Mixed Design

Mixed design is simply a combination of both block and event-related designs. This design
makes it possible to extract brain regions that process both transient and sustained response.
However, compared to other designs there are far more assumptions involved in this design
[114].

2.4

Analysis of fMRI Data

Data analysis involves three main procedures; preprocessing, statistics, and post processing. There are various software available that can analyze fMRI data, such as, FSL, AFNI,
and SPM. SPM requires MATLAB.

2.4.1

Pre-processing
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Figure 2.14: (1) Is a standard fMRI block design with A being the basal/resting state and
B being stimulated/task state. (2a) Is a rapid event-related design with fixed inter-stimulusintervals (ISI). (2b) Is also a rapid event-related design with the randomized ISI. (3) Is a
mixture of a block and an event-related design [80].

Preprocessing involves motion correction and filtering of the acquired data. During data
collection, since each 2D slice in a volume is collected at a slightly different time, there
are chances that the orientation of subsequent slice being slightly altered due movement of
the subject. Therefore, motion correction is performed. In motion correction, every slice
is realigned with its neighboring previous slice, within a volume. Then, each volume is
registered to the first volume which serves as a reference. For example, consider an fMRI
dataset of 100 volumes, with 30 slices in each volume. All 29 slices will be aligned with the
first slice as a reference, within a volume, then all 99 volumes will be registered to the first
reference volume. This procedure is carried out on the data acquired from each subject.

2.4.2

Statistics

After the data is preprocessed, statistical analysis is carried out to see if there is significant
activation in the collected data. Now that all the volumes and slices within each volume are
aligned for the 4D fMRI data, the time course of fMRI signal (the actual BOLD response)
can be plotted for every voxel in the data. The fMRI signal in each voxel can be defined as;
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y(t) = βx(t) + (t)

(2.4)

Where y(t) is the fMRI signal, x(t) is the stimuli pattern based on the design adopted
(block, event-related, or mixed design) for the experiment, β is the parameter estimate
(PE) for x(t), and (t) is the error value. The x(t) in Equation 2.4, in practice, is a stimuli
pattern convolved with the HRF, h(t), which gives a predicted BOLD response model that
is assumed to be a close fit of the actual fMRI signal. Figure 2.13, illustrates the process
of estimating a predicted BOLD response model. The value of β is indicative of how well
the predicted BOLD model (x(t)) fits with the fMRI signal waveform. Higher β value
indicates a better fit. If there are more than one kind of stimuli conditions in a design,
each condition is modeled as a separate x(t), known as explanatory variables (EVs). For
example, if there are two stimuli conditions, the equation is as follows,

y(t) = β1 x1 (t) + β2 x2 (t) + (t)

(2.5)

Depending on the number of stimuli conditions used, that many EVs can be modeled,
and the over all general linear model (GLM) will be as follows, for each voxel,

y(t) = β1 x1 (t) + β2 x2 (t) + .... + βi xi (t) + (t)

(2.6)

This GLM is tested for its fitting at each voxel with a user specified p-value. Therefore,
for n number of voxels, Equation 2.6, can be represented in form of a matrix,
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Equation 2.6, can be written in a more generic form as follows,

Y = βX + 

(2.8)

As mentioned earlier that β is a measure of the model fitting, after the β value is
assessed, t-statistics is calculated to see how significant is the fitting,

T =

β
σβ

(2.9)

If there is a multiple conditioned stimuli, each condition is modeled separately as an
EV, and each EV has its own β value. To determine if EV1 better fits the data than EV2,
a subtraction comparison is carried out between the two EVs, and its resultant β value is
again tested for its significance.
For an experiment that uses a block design with two conditions, A(rest) and B(task).
During statistical analysis of the data, the intensity trend for every voxel in the data is tested
for its fitting with the predicted BOLD response model. Suppose a data is collected over a
period of 4 minutes (240 seconds) with a duration for each condition of 30 seconds, and TR
of 2.5 seconds. There would be total of 240/2.5 = 96 volumes, with each condition lasting
across 30/2.5 = 12 volumes. Each volume represents a time point. Therefore, a timeseries
of intensity values for each voxel can be plotted in 96 time points. Each voxel’s intensity
trend is tested for it’s fit with the predicted model, for a user specified p-value (P < 0.05).
If the intensity of a voxel is high for the time points that fall under the condition B(task)
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Figure 2.15: Example of how the fMRI data is expressed after it is analyzed. Bottom
image shows activation in form of spatial brain maps where the red-yellow blobs represent
activation. The top image shows the temporal map of one voxels, and fitting of its intensity
patter with the predicted BOLD model. Adapted from Kashou 2014 [80].

and low for condition A(rest), and it’s trend significantly fits with the predicted BOLD
response model, then that voxel is reported as being activated. After all the active voxels
are identified, they are overlaid with color-maps. The color-maps are thresholded based on
the user specified intensity value which is also the z-score. Figure 2.15, is an example of
data and predicted model fitting, and the activation maps obtained after statistical analysis.
After the 4D fMRI image dataset is analyzed and assigned appropriate color-maps, it is
registered to an anatomical brain image to see the activation maps on a high resolution
brain image. If the experiment is done on more than one subject or multiple fMRI scanning
sessions are performed on one subject, each analyzed high resolution activation brain map
is registered to a common standard image space.
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Methods
This study was a team effort where each team member contributed his/her expertise towards successful completion of the study. The study involved; recruitment of convergence
insufficient (CI) patients and normal binocular vision (NBV) controls, preparation of visual
stimulus, selection of appropriate MRI & fMRI data acquisition parameters, and fMRI data
analysis.

3.1

Subject Recruitment

Five CI patients and five NBV controls were recruited for this study. The following were
the inclusion and exclusion criteria for selecting appropriate subjects for the study,

3.1.1

Eligibility Criteria

Inclusion Criteria for NBV Controls
• Age 18-30 years
• Best corrected visual acuity of 20/25 or better in each eye at distance and near
• Presence of normal binocular vision (NBV) by meeting all of the following criteria:
– Low horizontal heterophoria measurement by cover test at distance and near between 2∆ esophoria and 6∆ exophoria with no more than 6∆ between distance
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and near measures
– Adequate near point of convergence, less than 6 cm break
– Negative fusional vergence at near, greater than 7PD break/5PD recovery
– Positive fusional vergence at near greater than 10PD break/7PD recovery
– Normal accommodative amplitude OD (Monocular amplitudes of accommodation greater than 15-0.25x age as measured by push-up method)
– Random dot stereoacuity of 500” or better
• Eye exam with cycloplegic refraction within the past 3 months
• Willingness to purchase and wear glasses or contact lenses to correct refractive error,
if necessary
• No previous vision therapy, near addition lens use, or prism use
• Informed consent and willingness to participate in the study
• Ability to successfully complete baseline fMRI imaging

Inclusion Criteria for CI Patients
• Age 18-30 years
• Best corrected visual acuity of 20/25 or better in each eye at distance and near
• Presence of symptomatic convergence insufficiency (CI) by meeting all of the following criteria:
1) Exophoria at near at least greater than 4∆ than at far,
2) Receded near point of convergence of greater than 6 cm break,
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3) Insufficient positive fusional vergence (i.e., failing Sheard’s criterion or minimum normative positive fusional vergence (PFV) of 15∆ base-out blur (or
break if no blur)), and
4) CI symptom score of 21 or higher
• Accommodative amplitude of ≤ 20 cm
• Eye exam with cycloplegic refraction within the past 3 months
• Willingness to purchase and wear glasses or contact lenses to corrected refractive
error, if necessary
• Willingness to discontinue wearing base-in prism, if applicable
• Willingness to discontinue wearing a plus add, if applicable
• Informed consent and willingness to participate in the study
• No previous treatment with vision therapy

Exclusion Criteria for all Subjects
• Any positive ocular history for the following conditions: amblyopia, strabismus, vertical phoria > 1∆, high refractive error, refractive surgery, or manifest of latent nystagmus
• Systemic disease known to affect accommodation, vergence and occular motility
such as: multiple sclerosis, Graves’ thyroid disease, myasthenia gravis, diabetes,
Parkinson’s disease
• Current use of any color or systemic medication known to affect accommodation
or vergence such as anti-anxiety agents (e.g., Librium of Valium), anti-arrhythmic
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agents(e.g., Cifenline, Cibenzoline), anti-cholinergics(e.g., Motion sickness path (scopolamine)), bladder spasmolytic drugs (e.g., Propiverine), hydroxychloroquine, chloroquine, phenothiazines (e.g., Compazine, Mellaril, Thorazine), tricyclic antidepressants (e.g., Elavil, Nortriptyline, Tofranil)
• History of traumatic brain injury, neurological disease (e.g., MS, Parkinson’s), or any
condition that may conflict with obtaining normal fMRI scans

Exclusion Criteria for all Subjects due to fMRI
• Any surgical metals or pacemakers
• Any coronary stent(s), cardiac pacemakers, electronic stimulators and pumps, cerebral aneurysm clips, sensitive metallic medical implants, and metallic foreign bodies
• Any MR unsafe surgical implants or devices(Any “MR Conditional” implanys/devices must be evaluated by MR technologist or physicist)
• Metal foreign bodies in or proximal to the eye, brain, heart or spinal cord, or of
uncertain location
• Tattoos on the head or neck, tattoos not obtained by a licensed artist, or any extensive
tattoos (Participants with small tattoos below the shoulders may participate if the
tattoos are covered by damp cloths)
• Pregnancy
• Insufficient medical/surgical history on patient
• Refusal of patient to remove unsafe personal objects, clothing, jewelry, etc., before
entering the MRI scanning room for scanning procedure
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• Orthodontic work such as wearing braces on the teeth, etc., (for better image quality
purpose)
• Left-handed dominance

3.1.2

Recruitment and Eligibility Testing

OSU optometry clinic, reference from community physician, and advertisement were the
means through which individuals were recruited and identified as potential patients. Informed consent was obtained from the potential subjects before any testing was performed
on them. The eligibility vision examination was performed at The OSU College of Optometry to determine if a subject met the inclusion/exclusion criteria as a NBV control or a CI
patient. Subjects who met these criteria also completed a sample eye movement tasks that
they would do during the fMRI testing. This sample task was meant to familiarize subjects
with the stimulus prior to the actual fMRI runs. All subjects underwent fMRI testing while
performing eye movement tasks.

3.1.3

fMRI Scanner and Site Location

The Magnetic Resonance Image scanning was performed using a 3.0 Tesla imager (Siemens
Medical Systems, MR software version 12 with a 12-channel array head coil, Brainwave
software) at Center for Cognitive and Behavioral Brain Imaging (CCBBI), Psychology
Building, The Ohio State University.

3.1.4

fMRI Setup

The visual stimuli was projected from the control room onto a rear-projection screen mounted
on the head coil and was visible to the subjects through a tilted mirror placed above their
head. The mirror to subject eyes distance was approximately 12 cm and the distance of
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Figure 3.1: Red/blue 3D glasses.
Table 3.1: Functional and Anatomical Scanning Parameters
Parameters
Repetition time (TR)
Echo time (TE)
Matrix Size
Flip Angle (FA)
Slices Per Volume
Voxel Resolution

Functional Scans
2500 ms
28 ms
72 x 72
76°
44
3.0 mm3

Anatomical Scans
1950 ms
4.44 ms
224 x 256
12°
176
1.0 mm3

screen from the subject was approximately 70 cm. Head motion was avoided as much as
possible by firm cushions packed around the head and by the use of a head strap. Eye
movement activity were initially decided to be recorded by fMRI EyeLink eye-tracking
system, however, due to technical difficulties this idea was dropped, and binocular eye
movements were recorded off the monitor in the fMRI control room which did not track
eyes but provided the video feed of the eye movements.

3.1.5

fMRI Data Acquisition

Table 3.1, lists all the important parameters used in acquiring functional and anatomical
scans. EPI image sequence was used to collect the fMRI data, and T1 weighted MPRAGE
image sequence was used to acquire the anatomical data. All image slices, for both scans,
were acquired in an axial orientation, and the voxel were kept isotropic in dimensions.
The fMRI data acquisition process for each subject involved a quick 10 seconds initial
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brain scan called as a localizer. It was just to mark the location of the brain. Then, the
anatomical brain scan was performed which took approximately 7 mins. The anatomical
image serves as a reference for registration of the analyzed fMRI dataset, during the postprocessing phase of the analysis. It is used for viewing activation maps overlaid on a
high resolution brain image. After, anatomical images were acquired, fMRI scan for the
easy convergence task was initiated. This was done by pressing a common key on the
keyboard, in the control room, which started the visual stimulus presentation and fMRI
scans at the same time. The hard convergence task scan was also initiated in the same
fashion, subsequent to the easy task. Both easy and hard task scans lasted for 4 minutes,
10 seconds, each. The subjects were asked through the microphone in the control room,
after every scan, if they were feeling comfortable going ahead with the next scan. All
scans were carried out keeping the subject’s comfort as the top concern, during the entire
scanning procedure.

3.1.6

fMRI Visual Stimuli

The visual stimuli (VS) was prepared using the Visual Basic (VB) programming language.
The VS was based on triggering disparity driven step convergence eye movements. The
presentation of stimuli followed a standard block design. Rest (Off) condition for 20 seconds was alternated with task (On) condition for 30 seconds. Subjects viewed a random dot
stereogram with a small disparity box in the center, which appeared as popped out of the
screen, making it a 3D visual stimulus. The subjects wore 3D glasses while performing the
visual task, such that the left eye was covered with red filter and the right eye was covered
with the blue filter. Figure 3.1, is a picture of a similar red/blue 3D glasses used during
the experiment. During the “Off” condition, a visual stimulus of zero convergence demand
was presented. The zero convergence demand stimulus was a random dot stereogram with
purple dots, with the disparity box in the center. During the “On” condition, with each increasing convergence demand the purple area shrinked horizontally, and blue and red area
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Figure 3.2: (A) Represents zero convergence demand. (B) Represents low convergence
demand. (C) Represents high convergence demand.

started appearing on the sides. The left eye only perceived the red area due to red filter,
and right eye perceived only blue area due to blue filter. Therefore, as the blue area kept
increasing leftwards, the right eye was forced to converge and follow the movement of the
blue area, and same phenomena occurred with the left eye, for the red area that moved
rightwards. Along with the outward motion of the blue and red areas, the disparity in the
center also drove convergence accommodation in the subjects. Figure 3.2, express three
demands of convergence; starting form zero through high convergence demand.
The subjects performed the convergence task of two difficulty levels; an easy conver45

Figure 3.3: (A) Pattern of the stimuli presentation. Rest period for 20 seconds followed
by 30 seconds of convergence task. Within the 30 second period of convergence task,
increasing convergence demands were presented, each demand lasting for 6 seconds. (B)
Overall block design.

gence task and a hard convergence task. The pattern in which both the tasks were presented
to the subjects was the same, however, the amplitude of the convergence demands were different in the two tasks.

Easy Convergence Task
In the easy convergence task, during the “On” condition, increasing convergence demands
were presented in a step fashion. Each demand lasted for 6 seconds to give enough time
for the subjects to converge. The demand started from 4PD BO through 12PD BO at an
increment of 2PD BO, making total of five steps. “Off” condition was simply a 0PD BO
demand for 20 seconds.
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Hard Convergence Task
The hard convergence task followed the same pattern as the easy convergence task. However, the demands for this task started from 5PD BO through 25PD BO at an increment of
5PD BO.
The general schematic for both the tasks is illustrated in Figure 3.3.
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Analysis
After collecting the data, it was ready to be analyzed. Three software were used for analyzing the fMRI data; FEAT Version 6.00 (FSL 5.0.9) (Analysis Group, FMRIB, Oxford,
UK.) [115], JMP Version 11.0 (SAS Institute Inc.), and Talaraich Client Version 2.4.3 (Research Imaging Institute) [116, 117]. As all the 10 subjects were scanned for two tasks,
each subject had two fMRI dataset, total of 20 fMRI dataset to be analyzed.

4.1

fMRI Expert Analysis Tool (FEAT)

The fMRI data was analyzed using the FEAT tool. FEAT is a part of larger software package called FMRIB’s Software Library (FSL). It is a powerful model-based fMRI analysis
tool which lets the user describe the experimental design in form of a general linear model
(GLM), and then compares the GLM to the actual data. The model-data fitting is statistically calculated and represented in form of spatial brain maps overlaid with appropriate
color mapping that indicates brain activation. The tool also provides quantitative about
brain activation. Prepossessing of the data like, brain extraction, motion correction, intensity normalization, and spatial filtering is also possible in FEAT. Also, the post processing
steps like registration of functional brain maps to high resolution anatomical images and
then to standard space is facilitated in FEAT.
The FEAT analysis process includes two levels of analysis. In the first level analysis,
fMRI dataset from each subject is analyzed individually. In group level analysis, the outputs
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Figure 4.1: Work flow of first level analysis on individual fMRI dataset.

for the first level analysis are classified as groups (e.g., patient and control group) and
analyzed for group mean activation, and difference in the mean activation between groups.

4.2

First Level FEAT Analysis

First level analysis involves analyzing fMRI dataset of each subject, individually. Following were the steps taken to execute first level analysis. Figure 4.1, shows the work flow for
first level analysis of the fMRI data.

4.2.1

Preprocessing

The fMRI data was first pre-processed in the FEAT. Major data pre-processing steps included, brain extraction of the anatomical images, motion and slice timing correction, brain
extraction of the fMRI data, spatial smoothing, and intensity normalization.

49

Brain Extraction of Anatomical Images
This procedure is a part of pre-processing of the data, but it is carried out separately in the
brain extraction tool (BET), and not in the FEAT. BET helps in filtering out the non-brain
tissue matter from the anatomical brain image, and leaves behind only the brain image,
which is used later during post-processing of the data. The anatomical brain images on
which BET was performed in this study were T1 weighted brain images.

Motion & Slice Timing Correction
After brain extraction was completed, FEAT was initiated and raw fMRI dataset was uploaded into the FEAT. The raw data was then corrected for any head motions which may
have occurred due to subjects’ movements during the fMRI scans. This was done by selecting the Motion Correction FMRIB’s linear Registration Tool (MCFLIRT) option in the
FEAT. Also, since every slice in one fMRI volume is collected at a slightly different time,
the timeseries for each voxel in every volume had to be corrected using the slice time correction option. This step is necessary because during processing of the fMRI data, all slices
of a volume are assumed to have been acquired at one instant, exactly at the middle of the
relevant TR. For example, if an fMRI data is acquired using a TR of 3 seconds, each volume is acquired every 3 seconds. In reality, each slice in a volume is acquired at a slightly
different time within the 3 second TR period. However, during the processing phase, all
slices of a volume are assumed to have been acquired exactly at 1.5 seconds into the TR of
that volume. Hence, to account for this assumption, slice timing correction is performed by
selecting the fashion in which slices are acquired. In this study, all the slices were acquired
in an interleaved fashion.

Brain Extraction of the fMRI Data, Spatial Smoothing, & Intensity Normalization
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The non-brain matter from the fMRI image dataset was eliminated. Spatial smoothing of
the data was carried out. Spatial smoothing filters out noise from the data without eliminating valid activation. However, the extent of noise has to be specified. For this study, the
spatial extent of valid activation was expected to be greater than 5 millimeters. Therefore,
any activation less than 5 millimeters in extent was considered to be noise and filtered out.
Intensity normalization was carried out to eliminate variations in intensity across volumes
of an fMRI dataset. Variations in intensity occurs due to inhomogenity of the B0 field,
or due to realistic nature of the gradient coils, i.e., the gradient take certain time to reach
the maximum power after being turned on. This may cause initial volumes of a particular dataset to have a lower intensity than the final ones. Intensity variation is a major
issue in fMRI analysis as fMRI analysis is based deriving conclusions about activation by
quantifying the changes in intensities of the voxels.

4.2.2

Processing

Processing phase is the decisive phase during which decisions regarding brain activation
are made by statistically analyzing the fMRI data. The most important step during processing is GLM setup, followed by statistical analysis, and post statistical steps like applying
activation thresholds to the analyzed data.

GLM Setup
GLM setup involves developing a temporal model that closely describes the course of the
stimuli presentation. To do so, full model setup option was selected in the FEAT. This
opened a GLM graphical user interface (gui) in which temporal model of the experiment
can be developed. Under the GLM gui, only one explanatory variable (EV) was selected,
as subjects performed only one kind of eye movements, i.e., convergence, during the “On”
phase of the block (active phase of the task). Therefore, one EV was enough to model
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activation due to convergence. Under the EV setup tab, basic shape, custom (3 column
format) was selected, and a text file that contained information about the time course of the
stimuli presentation was uploaded. Based on information provided in the text file the, GLM
gui generated a temporal model which was convolved with HRF, and was a supposed close
imitation of the actual BOLD signal in the fMRI data. This model is called as a predicted
BOLD response model which was compared with the intensity patter of every voxel in the
fMRI dataset to look for significant activation, during the statistical analysis.

Statistics
Statistical analysis of the fMRI dataset is carried after all the post statistics directions are
programmed in the FEAT. Therefore, after setting up the GLM, post-statistics information
was fed into the FEAT. The procedure as to how the the FEAT carries out statistical analysis,
to find significant activation, is already described in the Chapter 2, under the Section 2.4.

Post Statistics
Post statistics procedure involved selecting the type of thresholding to be performed, designating the z-threshold value and p-value, and contrast making. A cluster based thresholding
with a z-threshold of greater than 2.3, and a p-value of less than 0.05 was selected. Which
means, only those voxel clusters which have an intensity value (z-score) of more than 2.3
will be reported as active clusters. Contrast masking was not required for the first level
analysis as there was only one activation condition of convergence for the experiment.
However, for the higher level analysis, when the mean activation images were compared
between patients and controls, contrast masking was carried out to look at the difference
between only the active brain regions in both the groups.

4.2.3

Post Processing
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During post processing, image rendering, registration of the fMRI images to high resolution
anatomical images and later to the standard space was carried out. For image rendering,
default FEAT options were kept unchanged. The brain extracted anatomical images which
would serve as reference for registration of the analyzed fMRI images, were uploaded in the
FEAT. This would generate functional maps overlaid on high resolution brain images. A
standard space MNI152 T1 weighted image was also selected to register the high resolution
functional image to the standard space. After all the settings were made in the FEAT, FEAT
tool was initialized by pressing on the GO option. It took 5-20 minutes for each fMRI
data to be analyzed. After analysis was complete, a FEAT output report appeared which
provided all the information, from the pre-processing steps through post processing steps,
including information regarding brain activation. Apart from generating a report, FEAT
also created FEAT directories for each analyzed fMRI data. These FEAT directories of
individual subjects contain all the needed information, and were later used for group level
analysis for group comparison.

4.3

Group Level FEAT Analysis

The group level analysis was also carried out in FEAT, as well. From the first level analysis,
a FEAT directory for each subject, one for each task, was created. These directories were
used for the group level analysis of controls and patients. Group level analysis for easy and
hard tasks was also carried out separately, i.e., controls and patients that performed easy
task were analyzed separately from the controls and patients that performed hard task.

4.3.1

Analysis of Easy & Hard Convergence Task

Group level analysis of easy task and hard task followed the same procedure as laid out
here. FEAT was switched to “Higer Level Analysis” mode, 10 analyzed FEAT directo-
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ries, 5 patients and 5 controls were uploaded into FEAT. Variance across the subjects was
ignored by selecting the “Fixed Effect” option, as the sample was too small to make conclusions about a larger population. Then, an appropriate location directory was selected
where the results from this analysis would get saved. Important part of group level FEAT
analysis was only the GLM setup, as the fRMI data was already processed in the first level
FEAT analysis. To meet the purpose of this experiment, a two group unpaired t-test was
chosen. This opened up a GLM setup gui in which the model for the patient vs. control
mean comparison was developed. The model was examined carefully, and setting up of
different contrasts was carried out. The contrasts of interest for this particular study were
to look at the differences in the activation between the controls and patients. To do so, first,
mean activation in the control and patient group was quantified, and then a subtraction
comparison was made between the two groups, through the student unpaired t-test. Figure
4.2, shows how the contrasts were developed in the GLM gui. The contrasts “patients >
controls” and “controls > patients” were masked with contrasts “controls mean” and “patients mean”. This contrast masking was done to see differences only in the active regions
of controls and patients. After all the required setting were made, the group level analysis
was initialized. After the analysis was over, an output report appeared which contained
both activation brain maps and quantitative information regarding the activation for each
contrast. Also, a group feat directory was generated as an output, at the user specified location. This directory contained all statistical information including z-stats images which
provide graphical representation of the activation maps with appropriate color mapping.
Some of these images are expressed in Chapter 5.1. The quantitative information from this
output report was utilized in the JMP to analyze the significance of tasks (easy and hard),
subjects (controls and patients), and ROIs. The quantitative information includes the number of active clusters, number of voxels in each cluster, and z-score, p-value and location
for every active voxels. There were total two group level FEAT outputs, one for each task,
and four contrast within each task.
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Figure 4.2: Contrast setup to look at the difference in the activation between patients (P)
and controls (C).

The FEAT outputs and the their contrast are as follows,
FEAT output 1: Easy task group FEAT analysis
Contrast 1: Patient mean
Contrast 2: Control mean
Contrast 3: Patient mean > Control mean
Contrast 4: Control mean > Patient mean
FEAT output 2: Hard task group FEAT analysis
Contrast 1: Patient mean
Contrast 2: Control mean
Contrast 3: Patient mean > Control mean
Contrast 4: Control mean > Patient mean
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4.4

Talairach Client

Talairach Client is an open source software that accepts locations of the brain voxels in form
of three dimensional co-ordinates (x,y,and z), and returns anatomical names for them. After
the FEAT outputs were generated, a set of co-ordinates were compiled in one temporary
text file of which all the co-ordinates from the contrast images of the following outputs
were a subset,
FEAT output 1: Easy task group FEAT analysis
Contrast 1: Patient mean
Contrast 2: Control mean
FEAT output 2: Hard task group FEAT analysis
Contrast 1: Patient mean
Contrast 2: Control mean
This text file was imported into the Talairach Client program, and anatomical names of the
brain regions for the provided co-ordinates were obtained. Following were the regions that
were produced by the program,
1. Right Cerebrum, Occipital Lobe, Lingual Gyrus
2. Right Cerebrum, Occipital Lobe, Cuneus
3. Right Cerebellum, Posterior Lobe, Declive
4. Left Cerebrum, Occipital Lobe, Lingual Gyrus
5. Left Cerebrum, Frontal Lobe, Middle Frontal Gyrus
6. Left Cerebrum, Frontal Lobe, Superior Frontal Gyrus
7. Right Cerebrum, Occipital Lobe, Middle Occipital Gyrus
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Table 4.1: Factor; Tasks and Subjects with their levels.
Factors Tasks
Level 1 Easy
Level 2 Hard

Subject
Controls
Patients

8. Left Cerebrum, Occipital Lobe, Cuneus
The above brain regions are the regions of interest (ROIs) where the mean activation
was be compared between the controls and the patients, for both the tasks.

4.5

SAS JMP 11

The JMP analysis was performed in order to assess significant factors and their interactions
that effected the outcome (activation) of this experiment. Which means, the goal of this
analysis was to find out whether the kind of task being performed, or the kind of subject
performing the task effected the activation (the z-score). Also, to find out which ROIs, out
of the selected eight ROIs, significantly differed from each other in activation. Lastly, what
combination of these tasks and subjects yielded highest and lowest activation in the ROIs?
To do this, a table was generated using custom design in JMP. Two factors namely, “Tasks”
and “Subjects” were modeled with two levels each. Both the factors and their levels are
expressed in the Table 4.1.
“Regions” was also modeled as a factor with 8 levels as there were 8 ROIs that showed
significant activation in this experiment. After the table was ready, it was filled with the
z-score values of the voxels that corresponded to the co-ordinates which were compiled
earlier in the temporary text file. Which means, this table not only accepted the z-scores of
the active voxels but also accepted z-scores of the inactive ones because they shared their
location with the active voxels from the other subject group or the other task. This was done
because the purpose of JMP analysis was not to detect activation, as this was already done
by FEAT, but to find out how significant was the difference in the activation between the
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two groups, two tasks, eight ROIs, and their interactions. Figure 4.3, represents the table
that was created using the custom design with only first 35 data points. There were total 140
data points. After all the data was entered into the table, a “Fit Model” run was performed
taking all factors and their interactions into account. This generated an output report that
expressed the significance of the model in form of an analysis of variance (ANOVA) table,
and an effect test table which indicated significance of each factor and their interactions.
The data was large enough to perform analysis with highest level of interaction without
falling short of degrees of freedom (DOF). However, after the analysis was completed and
the output report was created, the highest level interaction namely, Tasks-Subjects-Regions,
was eliminated as it wasn’t significant. After the highest level interaction was eliminated,
the model was reran. The results of the JMP analysis are presented in the Chapter 5.1.
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Figure 4.3: Custom designed table in JMP, filled with the data acquired from the FEAT
analysis. This table is only representative of initial 35 data points. There are total of 140
data points.
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Results
The results will be presented in two parts. In the first part, averaged analyzed images with
appropriate activation maps produced during FEAT analysis will be presented. The activation images presented in this part are the “z-stats” images, as the activation in them was
calculated through statistically analyzing intensity (z-score) of each voxel, in a particular
fMRI dataset. Presentation of the z-stats images will be sub-divided into two sections, as
there were two separate analyzed mean fMRI datasets, one for each task. For the second
part, the results obtained from JMP analysis will be presented.

5.1

FEAT Results

As there were total of 10 subjects (5 patients and 5 controls), and each of them were scanned
under two task conditions, the group level analysis was performed separately for each task.
This generated two group level FEAT outputs; one for easy task and one for hard task.

5.1.1

Easy Convergence Task

The mean activation observed in the patient group was significantly higher than the control
group, both in terms of spatial extent (number of active voxels) and amplitude (z-score), in
the ROIs, for a significance level of α = 0.05. The activation in the control group was more
localized in the visual cortex and cerebellum, and was of a much lower amplitude. Talairach
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P, 3

15

C, 3

15

Figure 5.1: Top row shows activation in the left cerebrum, frontal lobe, middle frontal
gyrus. Bottom row shows activation in the left cerebrum, frontal lobe, superior frontal
gyrus. Yellow-red color map is representative of mean activation in the patients. Blue-light
blue map represent mean activation in the controls. Threshold used to express activation
was 3 ≤ z-score ≤ 15. Mean activation maps of both controls and patients were overlaid
on a standard space T1 weighted brain template.

co-ordinates provided in similar fMRI studies by Alvarez et al (2010b), Jaswal et al (2014),
and Alkan et al (2011) on convergence insufficient patients [72, 118, 119], were applied to
the data of this study to see if similar results are obtained. The region of interest in the
above studies were, frontal eye field (FEF), supplementary eye field (SEF), dorsolateral
prefrontal cortex (DLPFC), posterior parietal cortex (PPC), cerebellum, and midbrain. The
activation maps for the above ROIs are presented in the Appendix A. Figures 5.1, 5.2, and
5.3, show mean activation in controls an patients, and Table 5.1, provides the quantitative
information of brain activation in terms of the z-scores of the voxels and their co-ordinates.
An unpaired t-test comparison confirmed that there was significantly higher activation
in the patients than the controls in the ROIs. Figure 5.4, is an image obtained through the
unpaired t-test comparison of mean activation maps of both groups (patients > controls),
enough to generically suggest that activation in patients is significantly higher than the
controls. For more images that point at activation in specific ROIs relating to patient >
control comparison, refer to Appendix A.
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Figure 5.2: Top row shows activation in the left cerebrum, occipital lobe, lingual gyrus.
Bottom row shows activation in the left cerebrum occipital lobe cuneus. Yellow-red color
map is representative of mean activation in the patients. Blue-light blue map represent
mean activation in the controls. Threshold used to express activation was 3 ≤ z-score ≤
15. Mean activation maps of both controls and patients were overlaid on a standard space
T1 weighted brain template.

P, 3

15

C, 3

15

Figure 5.3: Activation in cerebellum. Yellow-red color map is representative of mean
activation in the patients. Blue-light blue map represent mean activation in the controls.
Threshold used to express activation was 3 ≤ z-score ≤ 15. Mean activation maps of both
controls and patients were overlaid on a standard space T1 weighted brain template.
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Table 5.1: Activated regions with their Talairach co-ordinate locations, and z-scores. L:
left hemisphere, R: right hemisphere, C: controls, P: patients.
Region

L/R

P/C

X
(mm)

Y
(mm)

Z
(mm)

zscore

Frontal Lobe
Middle Frontal Gyrus (MFG)

L

-36

54

8

Superior Frontal Gyrus (SFG)

L

P
C
P
C

-32

50

22

6.35
0.98
5.2
-0.86

Occipital Lobe
Lingual Gyrus (LG)

L

P
C
P
C
P
C
P
C
P
C

-6

-90

-2

12

-78

-2

14

-92

10

14

-88

20

-20

-88

26

14

-78

-12

R
Middle Occipital Gyrus (MOG)

R

Cuneus

R
L

Posterior Lobe
Declive

R

P > C, 3

P
C

18.4
3.46
13.3
4.75
12.4
7.29
12.6
0.6
10.4
12.7
13.9
5.95

15

Figure 5.4: Unpaired t-test comparison of mean activation maps of patients and controls
(patients > controls). Purple-cool blue color map is representative of the brain regions
where activation in patients is greater than controls. Threshold used to express activation
was 3 ≤ z-score ≤ 15.
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P, 3

15

C, 3

15

Figure 5.5: Top row shows activation in the left cerebrum, frontal lobe, superior frontal
gyrus. Bottom row shows activation in the left cerebrum, occipital lobe, lingual gyrus.
Yellow-red color map is representative of mean activation in the patients. Blue-light blue
map represent mean activation in the controls. Threshold used to express activation was
3 ≤ z-score ≤ 15. Mean activation maps of both controls and patients were overlaid on a
standard space T1 weighted brain template.

5.1.2

Hard Convergence Task

A similar activation trend was noticed for the hard convegence task. The activation in
the patients was significantly higher than the controls in terms of spatial extent as well
as amplitude. The mean activation maps for both patients and controls are presented in
Figures 5.5, and 5.6. Table 5.2, provides the quantitative information of brain activation in
terms of the z-score values of the voxels and their co-ordinates.
The unpaired t-test comparison between the activation in patients versus controls also
yielded similar results as the easy convergence task. This test confirmed that activation in
the ROIs of the patients is significantly greater than the ROIs of the controls. Figure 5.7, is
the z-stats image of the unpaired t-test comparison.
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P, 3

15

C, 3

15

Figure 5.6: Top row shows activation in the left cerebrum, occipital lobe, cuneus. Bottom
row shows activation in the cerebellum. Yellow-red color map is representative of mean
activation in the patients. Blue-light blue map represent mean activation in the controls.
Threshold used to express activation was 3 ≤ z-score ≤ 15. Mean activation maps of both
controls and patients were overlaid on a standard space T1 weighted brain template.

P > C, 3

15

Figure 5.7: Regions where activation in patients is more than activation in controls while
performing the hard convergence task. Yellow-Hot red color map is representative of patients > control mean activation. Threshold used to express activation was 3 ≤ z-score ≤
15.
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Table 5.2: Activated regions with their Talairach co-ordinate locations, and z-scores. L:
left hemisphere, R: right hemisphere, C: controls, P: patients.
Region

L/R

P/C

X
(mm)

Y
(mm)

Z
(mm)

zscore

Frontal Lobe
Middle Frontal Gyrus (MFG)

L

-36

54

8

Superior Frontal Gyrus (SFG)

L

P
C
P
C

-32

50

22

4.34
1.34
5.43
0.37

Occipital Lobe
Lingual Gyrus (LG)

L

P
C
P
C
P
C
P
C
P
C

-6

-90

-2

12

-78

-2

14

-92

10

14

-88

20

-20

-88

26

14

-78

-12

R
Middle Occipital Gyrus (MOG)

R

Cuneus

R
L

Posterior Lobe
Declive

R
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P
C

16.8
7.74
15.8
8.51
12.5
9.59
17
3.1
15.9
5.6
15
8.51

Figure 5.8: ANOVA of Model.

5.2

Figure 5.9: Effect Test of Model.

JMP Results

The results from JMP analysis are presented here in a structured manner. First, significance of the overall model designed to analyze the quantitative FEAT output data will be
presented. Second, significance of each factor and their interactions will be presented in
form of an effect test table. Third, a connecting letter report derived through student t-test
for each factor and each interaction will be presented in order to highlight the significance
of different levels of each factor and interaction. For graphical representation of the data
points that were analyzed here, refer to Appendix B.

5.2.1

Analysis of Variance (ANOVA) & Effect Test of the Model

The ANOVA of the model in Figure 5.8, designed in JMP, showed that the model was
a significant one (p < 0.001). The effect test table in Figure 5.9, suggests that all the
factors had a significant effect on the activation (z-score). The interaction between factors,
“Subjects” and “Regions”, was also significant, alluding to a possibility of a differential
recruitment of brain regions between the controls and patients to perform the same task.
Other interactions did not have significant effect on the activation.

5.2.2

Factors

A student t-test was performed on all the factors. This generated a connecting letter report
for each factor. In a connecting letter report, like the one below, if levels of a particular
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factor do not share same letters, then those levels are considered significantly different
from each other.

Tasks
Connecting letter report for Tasks in Figure
5.10, suggested that the activation for hard
task was significantly different from the activation in the easy task, as the two tasks are
not connected with the same letters, and average activation amplitude for the hard task
was higher than that of easy task. This is Figure 5.10:
Tasks.
indicative of the possibility that hard con-

Connecting letter table for

vergence eye movements require more efforts from the subjects than the easy convergence
eye movements, which is reflected by a higher mean z-score, expressed in form of ”Least
Sq Mean” value, for the hard level, in the figure above.

Subjects
Connecting letter report for Subjects in Figure 5.11, suggested that average activation
in patient group was significantly different and higher than average activation in
the control group. It indicates that CI patients have to apply extra efforts than norFigure 5.11: Connecting letter table for Sub- mal binocular vision controls to perform
jects.
convergence eye movements. These extra
efforts by patients are reflected by a significantly higher activation value in the patients
compared to controls, in the figure above.
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Figure 5.12: Connecting letter report for Regions.

Regions
A student t-test of “Regions” generated a connecting letter report (Figure 5.12) that suggested that activation in the MFG and SFG, in the frontal lobe, was significantly different
from the activation in the remaining ROIs. The mean activation in MFG and SFG was
significantly lower than all the other ROIs, for both the tasks and both group of subjects.
The above connecting letter table for Regions expresses MFG and SFG at the bottom of the
table, highlighted with the red box, with lowest mean activation values. Activation in both
these regions was significantly different from all the other regions as they did not share the
same letters with other ROIs. However, activation in MFG was not significantly different
from the activation in the SFG, as they shared the same letters. Note that the mean activation value for middle frontal gyrus does not meet the criteria for activation. The criteria for
activation, during FEAT analysis, was set to z-score > 2.3.
The highest amount of activation occurred in different regions of the occipital lobe
such as, right and left LG, MOG, and cuneus.
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5.2.3

Interactions

A student t-test was performed on all possible factor interactions, as well. This was done
to examine how different levels of a factor interacted with different levels of all the other
factors to influence the response of the experiment. The response for this experiment was
the mean activation (z-score). A connecting letter report was generated for each interaction.

Tasks-Subjects
Connecting letter report for Task-Subject
interaction in Figure 5.13, suggested that
mean activation within the patients and
controls was significantly different depending on the kind of task they performed.
Mean activation in patients while performing hard task was significantly higher than
Figure 5.13: Connecting letter table for
the mean activation in them when performTasks-Subjects interaction.
ing easy task. Similar was the trend in the
controls, as well. This is because none of the levels are connected with the same letters.
This indicates that while patients, in general, are exerting more efforts than the controls to perform convergence eye movements, they are exerting significantly more efforts to
perform the hard convergence task than the easy convergence task. Similar is the situation
with the controls. While controls, in general, are exerting less efforts than the patients to
perform convergence eye movements, they are exerting significantly more efforts to perform the hard convergence task than the easy convergence task.

Subjects-Regions
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Figure 5.14: Connecting letter report Subjects-Regions interaction.
The connecting letter report for the Subjects-Regions interaction in Figure 5.14, suggested
that the levels in the red box were significantly different from the levels in the green box.
Which means, activation in the MFG and SFG of the patients was significantly different
and higher than the activation in the same regions of the controls. Note, that there was
virtually no activation in controls for those two ROIs as their least square mean values are
< 2.3.
This indicates that ROIs like MFG and SFG do not take part in encoding convergence eye movements, however when convergence eye movements become difficult under
clinical conditions such as CI, these ROIs actively take part in assisting convergence eye
movements at behest of extra efforts demanded by the CI patient.

Tasks-Regions
Connecting letter report for the Tasks-Regions interaction in Figure 5.15, generated from
the student t-test did not show significant difference in any of its levels. However, the
trend here to notice is that the two ROIs namely, MFG and SFG that showed significantly
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Figure 5.15: Connecting letter report for Tasks-Regions interaction.
low activation, figure at the bottom of the table in combination with both kind of tasks
suggesting that the activation in them is not effected by the difficulty level of the task.
This indicates that activation observed in these two ROIs was effected more by the
kind of subject performing the tasks than the kind of task being performed by the subjects.
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Conclusion
From the results obtained in FEAT and JMP analysis, it can be concluded that activation
in the patients is significantly higher than the activation in controls, both in terms of spatial extent and amplitude, in the ROIs. The mean z-stats activation images for controls
and patients, and z-stats activation images obtained by doing their subtraction comparison
also confirmed this conclusion. JMP analysis further added evidence to this conclusion
by reporting the same trend noticed in the z-stats images. Following are some specific
conclusions that were arrived to, through both the analysis,
1 Activation in the MFG and SFG of the patients was significantly higher than the
activation in the same regions of the controls. In fact, the controls did not show significant activation in these ROIs. A graph in Figure B.2 expresses z-scores of voxels
within each ROI for both patients and controls, with a green boundary at ≈ 2.3, beyond which is the criterion for activation. In MFG and SFG, all the corresponding
voxels that were active in the patients were inactive in the controls. On tacking more
specific locations within MFG and SFG, using voxel coordinates, it was found that
they belonged to the Brodmann area 10. This area is also called as anterior prefrontal
cortex (aPFC). This suggests that CI patients have to recruit more brain regions than
the binocularly normal controls to perform convergence eye movements. The extra
brain activation in patients is reflective of their extra efforts to do the task. Refer to
the connecting letter table of Subjects-Regions interaction in Figures 5.14, and B.2
in Appendix B.
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2 Results also suggested that difficulty of the task effected the amplitude and spatial
extent of activation in the subjects, in general, i.e., hard convergence task elicited
more activation than the easy convergence task in all subjects. Refer to the connecting letter table of Tasks in Figure 5.10, to see this trend. However, this trend is not
very evident looking at Figures B.1 and B.3.
3 The Tasks-Subjects interaction analysis in JMP suggested that combination of each
level of task with each group of subjects elicited significantly differential activation.
Highest activation was observed in patients when they performed the hard task, and
lowest activation was observed in the controls when they performed the easy task.
Refer to the connecting letter table for Tasks-Subjects interaction in Figure 5.13.
4 The findings of this study are contrary to the findings of similar earlier fMRI studies
carried out on CI patients. They reported higher activation in the controls than patient
during the baseline fMRI runs [74, 118]. However, the demand for convergence
in their experiment was randomized to eliminate any response due to prediction.
In this study, since the demands for convergence were presented in steps of equal
increments and duration, it was hard to differentiate response due prediction from the
actual convergence response. Also, correlation of the eye-movements of the subjects,
during the fMRI scans, with activation found in them was not achievable as binocular
eye-tracking idea using EyeLink system was dropped due to technical difficulties.
However, videographies of the eye movements recorded off the monitor in the MRI
control room were visually examined by a trained optometrist to get a verbal opinion
on whether the subjects properly performed the task or not.
Given all the pitfalls in this study, the findings of this study support the hypothesis that
activation in CI patients is higher, both in spatial extent and amplitude, than the NBV
controls.
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Future Work
Future work can involve conducting a similar study using a visual stimulus that presents
convergence demands in a randomized order than in a sequential order, to eliminate anticipation or prediction. A proper binocular eye-tracking should also be a part of future studies
to assess correlation of the activation in the ROIs with the eye movements. Future study
should also involve treating the CI patients with vision therapy that is meant to improve
their ability to perform convergence eye movements.
Based on the findings of this study, if a similar study is conducted that includes vision
therapy, the hypothesis would be that the extra activation observed in the aPFC region of
the CI patients, would significantly reduce post vision therapy. This hypothesis of training induced improvement resulting in reduction in neuronal activity is also supported by
an fMRI study conducted by Bezzola et al (2012). Bezzola’s study showed a significant
reduction of neural activity in 11 golf novoice after they had received 40 hr of golf training
[120].

75

Bibliography

[1] A v Graefe. Ueber myopia in distans. Archiv für Ophthalmologie, 1(1):158–186,
1855.
[2] Alexander Duane. A New Classification of the Motor Anomalies of the Eye: Based
Upon Physiological Principles, Together with Their Symptoms, Diagnosis, and
Treatment. JH Vail & Company, 1897.
[3] J Cooper and R Duckman. Convergence insufficiency: incidence, diagnosis, and
treatment. Journal of the American Optometric Association, 49(6):673, 1978.
[4] Convergence Insufficiency Treatment Trial (CITT) Study Group et al. The convergence insufficiency treatment trial: design, methods, and baseline data. Ophthalmic
epidemiology, 15(1), 2008.
[5] Mitchell Scheiman, Michael Rouse, Marjean Taylor Kulp, Susan Cotter, Richard
Hertle, and G Lynn Mitchell. Treatment of convergence insufficiency in childhood: a
current perspective. Optometry and vision science: official publication of the American Academy of Optometry, 86(5):420, 2009.
[6] CONVERGENCE INSUFFI. Randomized clinical trial of treatments for symptomatic convergence insufficiency in children. Arch Ophthalmol, 126(10):1336–
1349, 2008.
76

[7] MS Norn. Convergence insufficiency. Acta Ophthalmologica, 44(2):132–138, 1966.
[8] S Wybar Duke-Elder et al. Sstem of ophtahlmologyvolvi: ocular motility and strabismus. 1973.
[9] WH Kratka and Z Kratka. Convergence insufficiency; its frequency and importance.
The American orthoptic journal, 6:72–73, 1955.
[10] JAMES W WHITE and HAROLD W BROWN. Occurrence of vertical anomalies
associated with convergent and divergent anomalies: a clinical study. Archives of
Ophthalmology, 21(6):999, 1939.
[11] PR Kent and JH Steeve. Convergence insufficiency, incidence among military personnel and relief by orthoptic methods. Military surgeon, 112(3):202–205, 1953.
[12] RS Mahto. Eye strain from convergence insufficiency. BMJ, 2(5813):564–565,
1972.
[13] Jack W Passmore and Florence Maclean. Convergence insufficiency and its management: an evaluation of 100 patients receiving a course of orthoptics. American
journal of ophthalmology, 43(3):448–456, 1957.
[14] ML Mazow. The convergence insufficiency syndrome. J Pediatr Ophthalmol, 8:
243–244, 1971.
[15] J Cooper and N Jamal. Convergence insufficiency-a major review. Optometry (St.
Louis, Mo.), 83(4):137–158, 2012.
[16] JE Letourneau, N Lapierre, and A Lamont. The relationship between convergence
insufficiency and school achievement. American journal of optometry and physiological optics, 56(1):18–22, 1979.
[17] JE Letourneau and S Ducic. Prevalence of convergence insufficiency among elementary school children. Can J Optom, 50:194–197, 1988.
77

[18] Esteban Porcar and Antonio Martinez-Palomera. Prevalence of general binocular
dysfunctions in a population of university students. Optometry & Vision Science, 74
(2):111–113, 1997.
[19] Michael W Rouse, Eric Borsting, Leslie Hyman, Mohamed Hussein, Susan A Cotter, Mary Flynn, Mitchell Scheiman, Michael Gallaway, PAUL N DE LAND, et al.
Frequency of convergence insufficiency among fifth and sixth graders. Optometry
& Vision Science, 76(9):643–649, 1999.
[20] WL Mould. Recognition and management of atypical convergence insufficiency. J
Pediatr Ophthalmol, 7:212–4, 1970.
[21] CE Davies. Orthoptic treatment in convergence insufficiency. Canadian Medical
Association journal, 55(1):47, 1946.
[22] Sheila Mayou. The treatment of convergence deficiency, 1933-1944. The British
journal of ophthalmology, 30(6):354, 1946.
[23] NM Capobianco. Symposium: convergence insufficiency; incidence and diagnosis.
The American orthoptic journal, 3:13–17, 1953.
[24] HM Burian. Anomalies of the convergence and divergence functions and their treatment. In Symposium on Strabismus. Transactions of the New Orleans Academy of
Ophthalmology. St Louis, Mosby–Year Book, page 223, 1971.
[25] CE Davies. Etiology and management of convergence insufficiency. The American
orthoptic journal, 6:124–127, 1955.
[26] Judith B Lavrich. Convergence insufficiency and its current treatment. Current
opinion in ophthalmology, 21(5):356–360, 2010.
[27] Monroe J Hirsch. A study of forty-eight cases of convergence insufficiency at the
near point*. Optometry & Vision Science, 20(2):52–58, 1943.
78

[28] J Rosenfeld. Convergence insufficiency in children and adults. The American orthoptic journal, 17:93–97, 1966.
[29] Michael W Rouse, Leslie Hyman, Mohamed Hussein, Harold Solan, et al. Frequency of convergence insufficiency in optometry clinic settings. Optometry & Vision Science, 75(2):88–96, 1998.
[30] Ida Mann. Convergence deficiency. The British journal of ophthalmology, 24(8):
373, 1940.
[31] Mitchell Scheiman, Michael Gallaway, Kelly A Frantz, Robert J Peters, Stanley
Hatch, Madalyn Cuff, and G Lynn Mitchell. Nearpoint of convergence: test procedure, target selection, and normative data. Optometry & Vision Science, 80(3):
214–225, 2003.
[32] GREGORY J HAYES, BRETT E COHEN, MICHAEL W ROUSE, and PAUL N
DE LAND.

Normative values for the nearpoint of convergence of elementary

schoolchildren. Optometry & Vision Science, 75(7):506–512, 1998.
[33] Convergence Insufficiency Treatment Trial (CITT) Investigator Group et al. Validity
of the convergence insufficiency symptom survey: a confirmatory study. Optometry
and vision science: official publication of the American Academy of Optometry, 86
(4):357, 2009.
[34] Michael W Rouse, Eric J Borsting, G Lynn Mitchell, Mitchell Scheiman, Susan A
Cotter, Jeffrey Cooper, Marjean T Kulp, Richard London, and Janice Wensveen.
Validity and reliability of the revised convergence insufficiency symptom survey in
adults. Ophthalmic and Physiological Optics, 24(5):384–390, 2004.
[35] Karen D Brahm, Heidi M Wilgenburg, Jennine Kirby, Shanida Ingalla, Chea-Yo
Chang, and Gregory L Goodrich. Visual impairment and dysfunction in combat-

79

injured servicemembers with traumatic brain injury. Optometry & Vision Science,
86(7):817–825, 2009.
[36] Gregory L Goodrich, Jennine Kirby, Glenn Cockerham, Shanida P Ingalla, and
Henry L Lew. Visual function in patients of a polytrauma rehabilitation center:
A descriptive study. Journal of rehabilitation research and development, 44(7):929,
2007.
[37] M Cohen, Z Groswasser, R Barchadski, and A Appel. Convergence insufficiency in
brain-injured patients. Brain injury, 3(2):187–191, 1989.
[38] L Kowal. Ophthalmic manifestations of head injury. Australian and New Zealand
journal of ophthalmology, 20(1):35–40, 1992.
[39] D Abrams. Duke-Elder’s Practice of Refraction. London, 1993.
[40] Mitchell Scheiman, Jeffrey Cooper, G Lynn Mitchell, PAUL DE LAND, Susan Cotter, Eric Borsting, Richard London, and Michael Rouse. A survey of treatment
modalities for convergence insufficiency. Optometry & Vision Science, 79(3):151–
157, 2002.
[41] M Scheiman, H Herzberg, K Frantz, and M Margolies. A normative study of step
vergence in elementary schoolchildren. Journal of the American Optometric Association, 60(4):276–280, 1989.
[42] Mitchell Scheiman, G Lynn Mitchell, Susan Cotter, Marjean Taylor Kulp, Jeffrey
Cooper, Michael Rouse, Eric Borsting, Richard London, and Janice Wensveen. A
randomized clinical trial of vision therapy/orthoptics versus pencil pushups for the
treatment of convergence insufficiency in young adults. Optometry & Vision Science,
82(7):E583–E595, 2005.

80

[43] JEFFREY Cooper. Review of computerized orthoptics with specific regard to convergence insufficiency. Am J Optom Physiol Opt, 65(6):455–63, 1988.
[44] J Cooper. Diagnosis and treatment of accommodative and vergence anomalies using
computerized vision therapy. Practical Optometry, 9(1):6–11, 1998.
[45] JEFFREY Cooper, A Selenow, KJ Ciuffreda, et al. Reduction of asthenopia in patients with convergence insufficiency after fusional vergence training. Am J Optom
Physiol Opt, 1983.
[46] KM Daum, RP Rutstein, and JB Eskridge. Efficacy of computerized vergence therapy. American journal of optometry and physiological optics, 64(2):83–89, 1987.
[47] WW Somers, AW Happel, and JD Phillips. Use of a personal microcomputer for
orthoptic therapy. Journal of the American Optometric Association, 55(4):262–267,
1984.
[48] David A Goss and Bill B Rainey. Applied concepts in vision therapy-with accompanying disk. Optometry & Vision Science, 74(4):174–175, 1997.
[49] Mitchell Scheiman, G Lynn Mitchell, Susan Cotter, Jeffrey Cooper, Marjean Kulp,
Michael Rouse, Eric Borsting, Richard London, and Janice Wensveen. A randomized clinical trial of treatments for convergence insufficiency in children. Archives
of Ophthalmology, 123(1):14–24, 2005.
[50] Ian P Howard and Brian J Rogers. Binocular vision and stereopsis. Oxford University Press, 1995.
[51] Noorden GK Von. Binocular vision and ocular motility: theory and management of
strabismus. 1990.
[52] Gerald Westheimer and Arnold M Mitchell. Eye movement responses to convergence stimuli. AMA archives of ophthalmology, 55(6):848–856, 1956.
81

[53] GERALD WESTHEIMER and SIDNEY M BLAIR. Oculomotor defects in cerebellectomized monkeys. Investigative Ophthalmology & Visual Science, 12(8):618–
621, 1973.
[54] James W Gnadt and Lawrence E Mays. Neurons in monkey parietal area lip are
tuned for eye-movement parameters in three-dimensional space. Journal of neurophysiology, 73(1):280–297, 1995.
[55] Hideo Sakata, Masato Taira, Makoto Kusunoki, Akira Murata, Ken-ichiro Tsutsui,
Yuji Tanaka, W Nyi Shein, and Yukiko Miyashita. Neural representation of threedimensional features of manipulation objects with stereopsis. Experimental Brain
Research, 128(1-2):160–169, 1999.
[56] Masato Taira, Ken-Ichiro Tsutsui, Min Jiang, Kazuo Yara, and Hideo Sakata. Parietal neurons represent surface orientation from the gradient of binocular disparity.
Journal of neurophysiology, 83(5):3140–3146, 2000.
[57] Aldo Genovesio and Stefano Ferraina. Integration of retinal disparity and fixationdistance related signals toward an egocentric coding of distance in the posterior parietal cortex of primates. Journal of Neurophysiology, 91(6):2670–2684, 2004.
[58] Paul D Gamlin and Kyunghee Yoon. An area for vergence eye movement in primate
frontal cortex. Nature, 407(6807):1003–1007, 2000.
[59] FA Miles, JH Fuller, DJ Braitman, and BM Dow. Long-term adaptive changes in
primate vestibuloocular reflex. iii. electrophysiological observations in flocculus of
normal monkeys. Journal of Neurophysiology, 43(5):1437–1476, 1980.
[60] PD Gamlin and Robert J Clarke. Single-unit activity in the primate nucleus reticularis tegmenti pontis related to vergence and ocular accommodation. Journal of
Neurophysiology, 73(5):2115–2119, 1995.

82

[61] Hongyu Zhang and Paul DR Gamlin. Neurons in the posterior interposed nucleus
of the cerebellum related to vergence and accommodation. i. steady-state characteristics. Journal of Neurophysiology, 79(3):1255–1269, 1998.
[62] Paul DR Gamlin. Neural mechanisms for the control of vergence eye movements.
Annals of the New York Academy of Sciences, 956(1):264–272, 2002.
[63] Mineo Takagi, Rafael Tamargo, and David S Zee. Effects of lesions of the cerebellar
oculomotor vermis on eye movements in primate: binocular control. Progress in
brain research, 142:19–33, 2003.
[64] Takuya Nitta, Teppei Akao, Sergei Kurkin, and Kikuro Fukushima. Involvement
of the cerebellar dorsal vermis in vergence eye movements in monkeys. Cerebral
Cortex, 18(5):1042–1057, 2008.
[65] Takuya Nitta, Teppei Akao, Sergei Kurkin, and Kikuro Fukushima. .4-vergence eye
movement signals in the cerebellar dorsal vermis. Progress in brain research, 171:
173–176, 2008.
[66] T Sander, A Sprenger, G Neumann, B Machner, S Gottschalk, H Rambold, and
C Helmchen. Vergence deficits in patients with cerebellar lesions. Brain, 132(1):
103–115, 2009.
[67] LAWRENCE E Mays and JOHN D Porter. Neural control of vergence eye movements: activity of abducens and oculomotor neurons. J Neurophysiol, 52(4):743–
761, 1984.
[68] LAWRENCE E Mays, JOHN D Porter, PAUL DR Gamlin, and C Armando Tello.
Neural control of vergence eye movements: neurons encoding vergence velocity. J
Neurophysiol, 56(4):1007–21, 1986.

83

[69] Y Zhang, PDR Gamlin, and LE Mays. Antidromic identification of midbrain near
response cells projecting to the oculomotor nucleus. Experimental brain research,
84(3):525–528, 1991.
[70] Y Zhang, LE Mays, and PD Gamlin. Characteristics of near response cells projecting
to the oculomotor nucleus. Journal of Neurophysiology, 67(4):944–960, 1992.
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[92] Denis Le Bihan, Robert Turner, Tom A Zeffiro, Charles André Cuenod, Peter Jezzard, and Valerie Bonnerot. Activation of human primary visual cortex during visual
86

recall: a magnetic resonance imaging study. Proceedings of the National Academy
of Sciences, 90(24):11802–11805, 1993.
[93] Richard B Buxton and Lawrence R Frank. A model for the coupling between cerebral blood flow and oxygen metabolism during neural stimulation. Journal of Cerebral Blood Flow & Metabolism, 17(1):64–72, 1997.
[94] Nikos K Logothetis, Jon Pauls, Mark Augath, Torsten Trinath, and Axel Oeltermann.
Neurophysiological investigation of the basis of the fmri signal. Nature, 412(6843):
150–157, 2001.
[95] Nikos K Logothetis. The underpinnings of the bold functional magnetic resonance
imaging signal. The Journal of Neuroscience, 23(10):3963–3971, 2003.
[96] Essa Yacoub, Amir Shmuel, Josef Pfeuffer, Pierre-Francois Van De Moortele, Gregor Adriany, Kamil Ugurbil, and Xiaoping Hu. Investigation of the initial dip in fmri
at 7 tesla. NMR in Biomedicine, 14(7-8):408–412, 2001.
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Appendix A
This appendix provides the mean brain activation maps for both groups of subjects (patients
and controls), and for both levels of task (easy and hard). The purpose of this appendix is
to provide images that show comparison of the activation between patients and controls,
and between easy and hard task, in the ROIs that were investigated by similar previous
studies[74, 118]. The ROIs are as follows; FEF, DLPFC, PEF, cerebellum and midbrain.
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Figure A.1: Easy task: Both rows show activation in the frontal eye field (FEF) region
of the brain. Yellow-red color map is representative of mean activation in the patients.
Blue-light blue map represent mean activation in the controls. Threshold used to express
activation was 3 ≤ z-score ≤ 15. Mean activation maps of both controls and patients were
overlaid on a standard space T1 weighted brain template.
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Figure A.2: Easy task: Both rows show activation in the dorsolateral prefrontal cortex region of the brain. Yellow-red color map is representative of mean activation in the patients.
Blue-light blue map represent mean activation in the controls. Threshold used to express
activation was 3 ≤ z-score ≤ 15. Mean activation maps of both controls and patients were
overlaid on a standard space T1 weighted brain template.
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Figure A.3: Easy task: Both rows show activation in the parietal eye filed (PEF)region
of the brain. Yellow-red color map is representative of mean activation in the patients.
Blue-light blue map represent mean activation in the controls. Threshold used to express
activation was 3 ≤ z-score ≤ 15. Mean activation maps of both controls and patients were
overlaid on a standard space T1 weighted brain template.
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Figure A.4: Easy task: Top row shows activation in the supplementary eye field (SEF)
region of the brain. Bottom row shows activation in the cerebellum and midbrain. Yellowred color map is representative of mean activation in the patients. Blue-light blue map
represent mean activation in the controls. Threshold used to express activation was 3 ≤ zscore ≤ 15. Mean activation maps of both controls and patients were overlaid on a standard
space T1 weighted brain template.
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Figure A.5: Easy task: Both rows show higher activation in the FEF for patients compared to controls. Purple-cool blue color map is representative of patients > control mean
activation. Threshold used to express activation was 3 ≤ z-score ≤ 15.
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Figure A.6: Easy task: Both rows show higher activation in the DLPFC for patients compared to controls. Purple-cool blue color map is representative of patients > control mean
activation. Threshold used to express activation was 3 ≤ z-score ≤ 15.
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Figure A.7: Easy task: Both rows show higher activation in the PEF of patients compared to
controls. Purple-cool blue color map is representative of patients > control mean activation.
Threshold used to express activation was 3 ≤ z-score ≤ 15.
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Figure A.8: Easy task: Top row shows higher activation in the SEF of patients compared
to controls. Bottom row shows higher activation in the cerebellum and midbrain of the
patients compared to controls. Purple-cool blue color map is representative of patients >
control mean activation. Threshold used to express activation was 3 ≤ z-score ≤ 15.
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Figure A.9: Hard task: Both rows show activation in the frontal eye field (FEF) region
of the brain. Yellow-red color map is representative of mean activation in the patients.
Blue-light blue map represent mean activation in the controls. Threshold used to express
activation was 3 ≤ z-score ≤ 15. Mean activation maps of both controls and patients were
overlaid on a standard space T1 weighted brain template.
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Figure A.10: Hard task: Both rows show activation in the DLPFC region of the brain.
Yellow-red color map is representative of mean activation in the patients. Blue-light blue
map represent mean activation in the controls. Threshold used to express activation was
3 ≤ z-score ≤ 15. Mean activation maps of both controls and patients were overlaid on a
standard space T1 weighted brain template.
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Figure A.11: Hard task: Both rows show activation in the parietal eye filed (PEF)region
of the brain. Yellow-red color map is representative of mean activation in the patients.
Blue-light blue map represent mean activation in the controls. Threshold used to express
activation was 3 ≤ z-score ≤ 15. Mean activation maps of both controls and patients were
overlaid on a standard space T1 weighted brain template.
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Figure A.12: Hard task: Top row shows activation in the supplementary eye field (SEF)
region of the brain. Bottom row shows activation in the cerebellum and midbrain. Yellowred color map is representative of mean activation in the patients. Blue-light blue map
represent mean activation in the controls. Threshold used to express activation was 3 ≤ zscore ≤ 15. Mean activation maps of both controls and patients were overlaid on a standard
space T1 weighted brain template.
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Figure A.13: Hard task: Both rows show higher activation in the FEF for patients compared to controls. Yellow-Hot red color map is representative of patients > control mean
activation. Threshold used to express activation was 3 ≤ z-score ≤ 15.
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Figure A.14: Hard task: Both rows show higher activation in the DLPFC for patients
compared to controls. Yellow-Hot red color map is representative of patients > control
mean activation. Threshold used to express activation was 3 ≤ z-score ≤ 15.
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Figure A.15: Hard task: Both rows show higher activation in the PEF of patients compared to controls. Yellow-Hot red color map is representative of patients > control mean
activation. Threshold used to express activation was 3 ≤ z-score ≤ 15.
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Figure A.16: Hard task: Top row shows higher activation in the SEF of patients compared
to controls. Bottom row shows higher activation in the cerebellum and midbrain of the
patients compared to controls. Yellow-Hot red color map is representative of patients >
control mean activation. Threshold used to express activation was 3 ≤ z-score ≤ 15.
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Appendix B
This appendix provides graphical account of the JMP results presented in the results chapter. It includes three graphs; Z-score vs. Subjects/Tasks, Z-score vs. Subjects/Regions, and
Z-score vs. Task/Regions.
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Figure B.1: This graph represents z-scores of the data points (voxels) obtained through
FEAT analysis. Locations (coordinates) of the voxels across both groups of subjects and
both levels of task are consistent. The green line marks the z-score boundary at ≈ 2.3,
beyond which is the criterion for activation, i.e., any voxels below the green line is not
active.
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Figure B.2: This graph represents z-scores of the data points (voxels) obtained through FEAT analysis. Locations (coordinates) of the
voxels across both groups of subjects are consistent. The green line marks the z-score boundary at ≈ 2.3, beyond which is the criterion
for activation, i.e., any voxels below the green line is not active. Activation in patients is generally higher across all ROIs compared to
controls. However, there is no activation in the MFG and SFG regions of the controls, whereas, there is significant activation in the same
ROIs of the patients.
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Figure B.3: This graph represents z-scores of the data points (voxels) obtained through FEAT analysis. Locations (coordinates) of the
voxels across both levels of task are consistent. The green line marks the z-score boundary at ≈ 2.3, beyond which is the criterion for
activation, i.e., any voxels below the green line is not active. Activation in the MFG and SFG regions is significantly lower than other
ROIs, for both levels of task.

